<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id><journal-id journal-id-type="iso-abbrev">Dis Model Mech</journal-id><journal-id journal-id-type="publisher-id">DMM</journal-id><journal-id journal-id-type="hwp">dmm</journal-id><journal-title-group><journal-title>Disease Models &#x00026; Mechanisms</journal-title></journal-title-group><issn pub-type="ppub">1754-8403</issn><issn pub-type="epub">1754-8411</issn><publisher><publisher-name>The Company of Biologists Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4852503</article-id><article-id pub-id-type="pmid">26822477</article-id><article-id pub-id-type="doi">10.1242/dmm.022905</article-id><article-id pub-id-type="publisher-id">DMM022905</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Atkinson</surname><given-names>Sara Marie</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref><xref ref-type="author-notes" rid="AN2">&#x02021;</xref><xref ref-type="corresp" rid="cor1">&#x000b6;</xref></contrib><contrib contrib-type="author"><name><surname>Hoffmann</surname><given-names>Ute</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hamann</surname><given-names>Alf</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Bach</surname><given-names>Emil</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Danneskiold-Sams&#x000f8;e</surname><given-names>Niels Banhos</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kristiansen</surname><given-names>Karsten</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Serikawa</surname><given-names>Kyle</given-names></name><xref ref-type="aff" rid="af5">5</xref><xref ref-type="author-notes" rid="AN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Fox</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="af6">6</xref><xref ref-type="author-notes" rid="AN2">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Kruse</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Haase</surname><given-names>Claus</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Skov</surname><given-names>S&#x000f8;ren</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Nansen</surname><given-names>Anneline</given-names></name><xref ref-type="aff" rid="af7">7</xref><xref ref-type="author-notes" rid="AN3">&#x000a7;</xref></contrib></contrib-group><aff id="af1"><label>1</label><institution>Department of Diabetes Complications Research, Global Research, Novo Nordisk A/S</institution>, <addr-line>Maaloev 2760</addr-line>, <country>Denmark</country></aff><aff id="af2"><label>2</label><addr-line>Department of Veterinary Disease Biology</addr-line>, <institution>University of Copenhagen</institution>, <addr-line>Frederiksberg 1870</addr-line>, <country>Denmark</country></aff><aff id="af3"><label>3</label><addr-line>Experimentelle Rheumatologie</addr-line>, <institution>Deutsches Rheuma-Forschungszentrum and Charit&#x000e9;-Universit&#x000e4;tsmedizin Berlin</institution>, <addr-line>Berlin 10117</addr-line>, <country>Germany</country></aff><aff id="af4"><label>4</label><addr-line>Laboratory of Genomics and Molecular Biomedicine, Department of Biology</addr-line>, <institution>University of Copenhagen</institution>, <addr-line>Copenhagen 2100</addr-line>, <country>Denmark</country></aff><aff id="af5"><label>5</label><institution>Benaroya Research Institute</institution>, <addr-line>Seattle, WA 98101</addr-line>, <country>USA</country></aff><aff id="af6"><label>6</label><institution>Immunexpress</institution>, <addr-line>Seattle, WA 98109</addr-line>, <country>USA</country></aff><aff id="af7"><label>7</label><addr-line>Department of Pharmacology</addr-line>, <institution>Zealand Pharma</institution>, <addr-line>Glostrup 2600</addr-line>, <country>Denmark</country></aff><author-notes><fn id="AN1" fn-type="present-address"><label>*</label><p>Present address: Benaroya Research Institute, 1201 9th Avenue, Seattle, WA 98101, USA.</p></fn><fn id="AN2" fn-type="present-address"><label>&#x02021;</label><p>Present address: Immunexpress, 425 Pontius Avenue North, Suite 430, Seattle, WA 98109, USA.</p></fn><fn id="AN3" fn-type="present-address"><label>&#x000a7;</label><p>Present address: Zealand Pharma, Smedeland 36, 2600 Glostrup, Denmark.</p></fn><corresp id="cor1"><label>&#x000b6;</label>Author for correspondence (<email>sara.marie.atkinson@gmail.com</email>)</corresp></author-notes><pub-date pub-type="ppub"><day>1</day><month>4</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>4</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the							<pub-date pub-type="ppub"/>. --><volume>9</volume><issue>4</issue><fpage>427</fpage><lpage>440</lpage><history><date date-type="received"><day>21</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016. Published by The Company of Biologists Ltd</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p></license><?release-delay 0|0?></permissions><self-uri content-type="pdf" xlink:href="dmm-9-022905.pdf"/><abstract><title>ABSTRACT</title><p>Rodent models of arthritis have been extensively used in the elucidation of rheumatoid arthritis (RA) pathogenesis and are instrumental in the development of therapeutic strategies. Here we utilise delayed-type hypersensitivity arthritis (DTHA), a model in C57BL/6 mice affecting one paw with synchronised onset, 100% penetrance and low variation. We investigate the role of regulatory T cells (T<sub>regs</sub>) in DTHA through selective depletion of T<sub>regs</sub> and the role of IL-17 in connection with T<sub>reg</sub> depletion. Given the relevance of T<sub>regs</sub> in RA, and the possibility of developing T<sub>reg</sub>-directed therapies, this approach could be relevant for advancing the understanding of T<sub>regs</sub> in inflammatory arthritis. Selective depletion of T<sub>regs</sub> was achieved using a <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mouse, which expresses the diphtheria toxin receptor (DTR) and enhanced green fluorescent protein (eGFP) under control of the <italic>F</italic><italic>oxp3</italic> gene. Anti-IL-17 monoclonal antibody (mAb) was used for IL-17 blockade. Numbers and activation of T<sub>regs</sub> increased in the paw and its draining lymph node in DTHA, and depletion of T<sub>regs</sub> resulted in exacerbation of disease as shown by increased paw swelling, increased infiltration of inflammatory cells, increased bone remodelling and increased production of inflammatory mediators, as well as increased production of anti-citrullinated protein antibodies. Anti-IL-17 mAb treatment demonstrated that IL-17 is important for disease severity in both the presence and absence of T<sub>regs</sub>, and that IL-17 blockade is able to rescue mice from the exacerbated disease caused by T<sub>reg</sub> depletion and caused a reduction in RANKL, IL-6 and the number of neutrophils. We show that T<sub>regs</sub> are important for the containment of inflammation and bone remodelling in DTHA. To our knowledge, this is the first study using the <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mouse on a C57BL/6 background for T<sub>reg</sub> depletion in an arthritis model, and we here demonstrate the usefulness of the approach to study the role of T<sub>regs</sub> and IL-17 in arthritis.</p></abstract><abstract abstract-type="precis"><p><bold>Summary:</bold> This paper increases the understanding of disease drivers and regulators in delayed-type hypersensitivity arthritis, a robust and reproducible arthritis model in C57BL/6 mice.</p></abstract><kwd-group><title>KEY WORDS</title><kwd>Rheumatoid arthritis</kwd><kwd>Regulatory T cells</kwd><kwd>IL-17</kwd><kwd>Neutrophils</kwd><kwd>C57BL/6</kwd><kwd>ACPA</kwd><kwd>Microbiota</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Rodent models of arthritis have been extensively used in the process of elucidating the pathogenesis of rheumatoid arthritis (RA), a chronic inflammatory disease characterised by chronic joint inflammation and bone erosion, and they are instrumental in the development of new therapeutic strategies (<xref rid="DMM022905C2" ref-type="bibr">Asquith et al., 2009</xref>). Delayed-type hypersensitivity arthritis (DTHA) is an arthritis model in C57BL/6 (B6) mice that is characterised by synchronised onset, 100% penetrance and low variation. DTHA is induced by modifying a protein-antigen-induced delayed-type hypersensitivity response in the paw by administration of an anti-type-II-collagen antibody cocktail (anti-CII) between immunisation and challenge. The result is severe inflammatory arthritis affecting one, pre-defined, hind paw (<xref rid="DMM022905C3" ref-type="bibr">Atkinson et al., 2012</xref>). Notably, the anti-CII dose required for DTHA is five- to eight-times lower than required for induction of collagen-antibody-induced arthritis (CAIA) in B6 mice (<xref rid="DMM022905C20" ref-type="bibr">Hutamekalin et al., 2009</xref>).</p><p>Owing to their well-established role in controlling inflammation in many animal models, we hypothesise that regulatory T cells (T<sub>regs</sub>) play a role in the resolution of inflammation in DTHA. It has been shown in mouse models of arthritis that deficiency or depletion of T<sub>regs</sub> exacerbates disease, and increasing numbers of T<sub>regs</sub> can reduce disease activity (<xref rid="DMM022905C15" ref-type="bibr">Gizinski and Fox, 2014</xref>; <xref rid="DMM022905C25" ref-type="bibr">Kelchtermans et al., 2009</xref>; <xref rid="DMM022905C41" ref-type="bibr">Miyara et al., 2014</xref>; <xref rid="DMM022905C44" ref-type="bibr">Noack and Miossec, 2014</xref>; <xref rid="DMM022905C63" ref-type="bibr">Zaiss et al., 2010</xref>)<italic>.</italic> The development of a more sustained disease phenotype in the absence of T<sub>regs</sub> would let us study disease drivers unchecked by this immunoregulatory cell subset and to identify which disease driver mechanisms are suppressed by T<sub>regs</sub>
<italic>in vivo</italic> in experimental arthritis. The purpose of the present study was therefore to investigate the mechanisms of self-limiting disease in DTHA through selective depletion of T<sub>regs</sub> after disease induction. T<sub>reg</sub> depletion studies in experimental arthritis models are scant and have mainly used the anti-CD25 approach. Anti-CD25 treatment in collagen-induced arthritis (CIA) accelerates disease (<xref rid="DMM022905C24" ref-type="bibr">Kelchtermans et al., 2005</xref>; <xref rid="DMM022905C43" ref-type="bibr">Morgan et al., 2003</xref>). Administration of anti-CD25 prior to induction exacerbates glucose-6-phospate isomerase (G6PI)-induced arthritis (<xref rid="DMM022905C13" ref-type="bibr">Frey et al., 2010</xref>) and antigen-induced arthritis (AIA) (<xref rid="DMM022905C12" ref-type="bibr">Frey et al., 2005</xref>). However, using anti-CD25 antibodies for depletion of T<sub>regs</sub> also targets effector T cells (T<sub>eff</sub>). The <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mouse allows selective depletion of T<sub>regs</sub> without affecting T<sub>eff</sub>. This mouse expresses a fusion of a diphtheria toxin receptor (DTR) and enhanced green fluorescent protein (eGFP) under the control of the forkhead box protein 3 (<italic>Foxp3</italic>) gene locus, which means that T<sub>regs</sub> can be selectively depleted by administration of diphtheria toxin (DT) (<xref rid="DMM022905C9" ref-type="bibr">Feuerer et al., 2009</xref>; <xref rid="DMM022905C29" ref-type="bibr">Lahl et al., 2007</xref>). T<sub>reg</sub> depletion in <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mice on a DBA/1 background exacerbated G6PI-induced arthritis (<xref rid="DMM022905C21" ref-type="bibr">Irmler et al., 2014</xref>). However, to our knowledge, this is the first study to address, in-depth, the use of the <italic>Fox</italic><italic>p3-DTRe-GFP</italic> mouse for T<sub>reg</sub> depletion in experimental arthritis and the first to use the <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mouse on a B6 background in experimental arthritis.</p><p>RA has recently been associated with changes in the gut microbiota (<xref rid="DMM022905C51" ref-type="bibr">Scher et al., 2013</xref>; <xref rid="DMM022905C64" ref-type="bibr">Zhang et al., 2015</xref>). In spontaneous mouse models of autoimmune arthritis, joint inflammation is attenuated under germ-free conditions, but colonisation of the gut with commensal microbes is sufficient to elicit joint inflammation comparable to that observed in conventional mice (<xref rid="DMM022905C1" ref-type="bibr">Abdollahi-Roodsaz et al., 2008</xref>; <xref rid="DMM022905C61" ref-type="bibr">Wu et al., 2010</xref>). In these models, the colonisation of the gut resulted in a perturbed T<sub>reg</sub>/T<sub>eff</sub> balance, which was associated with disease onset and progression. The interplay between T<sub>regs</sub> and the gut microbiota modulates T<sub>reg</sub> abundance and function and might thereby also affect onset and progression of arthritis. Therefore, we also analysed the fecal microbiota following DTHA induction alone and in conjunction with T<sub>reg</sub> depletion.</p><p>In the present study, we found that depleting T<sub>regs</sub> after onset of DTHA led to an exacerbation of arthritis. Inflammatory cell infiltration, osteoclast activation and bone erosion were increased in T<sub>reg</sub>-depleted mice. T<sub>reg</sub> depletion also increased levels of anti-mutated-citrullinated-vimentin (MCV) antibodies, indicating an increase in autoimmunity associated with increased protein citrullination. Production of a wide range of cytokines and chemokines was increased, including IL-17, a cytokine involved in the pathogenesis of both RA and murine experimental arthritis. We show that treating T<sub>reg</sub>-depleted mice with anti-IL-17 monoclonal antibody (mAb) rescues them from exacerbation of disease through a reduction of circulating neutrophils and a reduction in IL-6 and receptor-activator of nuclear factor &#x003ba;B ligand (RANKL).</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2a"><title>A highly activated and proliferating subset of T<sub>regs</sub> is found in the lymph node draining the arthritic paw early after disease onset</title><p>We investigated the dynamics of T<sub>regs</sub> in DTHA by analysing the popliteal lymph node draining the arthritic paw (dPLN), the popliteal lymph node draining the control paw (ndPLN), paw infiltrate and blood at different time points during disease by flow cytometry (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>A). T<sub>regs</sub> were defined as live CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> cells and T<sub>eff</sub> cells by inverting the CD25<sup>+</sup>FoxP3<sup>+</sup> gate within the CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup> gate (full gating strategy shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S1A</uri>). T<sub>regs</sub> were most abundant in the dPLN on day 2 and 4 after DTHA induction and were still elevated compared to day 1 and na&#x000ef;ve mice on day 7. The increase in T<sub>reg</sub> number in the dPLN was also reflected in blood (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>B). A dramatic increase in activated (CD44<sup>+</sup>) and proliferating (Ki67<sup>+</sup>) T<sub>regs</sub> was seen in the dPLN, but not in the ndPLN or in blood (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>B, bottom graphs). Analysis of <italic>F</italic><italic>oxp3</italic> mRNA showed a significantly higher <italic>Fox</italic><italic>p3</italic> expression in paws on day 3 and 8 compared to before arthritis induction (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>C). The same was seen with <italic>C</italic><italic>tla4</italic> mRNA, which codes for the surface marker cytotoxic T-lymphocyte-associated protein 4 (CTLA4) found on T<sub>regs</sub> and memory T cells, but to a greater extent on T<sub>regs</sub> (<xref rid="DMM022905C22" ref-type="bibr">Jago et al., 2004</xref>) (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>C). No increase in T<sub>reg</sub> numbers in blood or popliteal lymph nodes was observed during the immunisation phase of DTHA (from na&#x000ef;ve to day 0), so we also analysed the inguinal lymph nodes (ILNs), which drain the immunisation sites, in na&#x000ef;ve mice and immediately prior to methylated bovine serum albumin (mBSA) challenge. In these lymph nodes a dramatic increase in the frequency of both T<sub>reg</sub> and T<sub>eff</sub> cells was observed (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>D), but this increase was not reflected in the number of circulating T<sub>regs</sub> or T<sub>eff</sub> on day 0 (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>B). Interestingly, a subpopulation of CD25<sup>hi</sup>FoxP3<sup>hi</sup> T<sub>regs</sub> was found in the dPLN but not in the ndPLN or blood (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>E,F). These CD25<sup>hi</sup>FoxP3<sup>hi</sup> T<sub>regs</sub> were found to possess an activated phenotype and were actively proliferating already from day 1 post-DTHA induction (<xref ref-type="fig" rid="DMM022905F1">Fig.&#x000a0;1</xref>G). We also analysed cells isolated from the arthritic paw on day 2 and 4 after DTHA induction and found the fraction of T<sub>regs</sub> of total T cells to increase from 12.17&#x000b1;1.09% to 14.70&#x000b1;0.63% from day 2 to 4 (mean&#x000b1;s.e.m., <italic>P</italic>=0.079, Student's <italic>t</italic>-test). Analysis of immune cells isolated from non-inflamed paws is not feasible owing to the very low number of cells that it is possible to harvest. We also found subpopulations of CD25<sup>hi</sup>FoxP3<sup>hi</sup> and Ki67<sup>+</sup> T<sub>regs</sub> in the paw. Among paw infiltrating T cells on day 2 and day 4, we found 33.72&#x000b1;4.16% and 23.04&#x000b1;1.55% of T<sub>regs</sub> to be CD25<sup>hi</sup>FoxP3<sup>hi</sup> (mean&#x000b1;s.e.m., <italic>P</italic>=0.044, Student's <italic>t</italic>-test) and 82.16&#x000b1;1.3% and 86.35&#x000b1;1.2% of T<sub>regs</sub> to be Ki67<sup>+</sup> (mean&#x000b1;s.e.m., <italic>P</italic>=0.034, Student's <italic>t</italic>-test), respectively. In summary, we observed increased numbers of activated and proliferating T<sub>regs</sub> in the dPLN and paw early after mBSA challenge in DTHA.
<fig id="DMM022905F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold>Dynamics and phenotypic characterisation of regulatory T cells (T<sub>regs</sub>) during delayed-type hypersensitivity arthritis (DTHA).</bold> (A) DTHA was induced by immunising mice with methylated bovine serum albumin (mBSA) emulsified in complete Freund's adjuvant (CFA) on day &#x02212;7, followed by an intravenous (i.v.) dose of an anti-type-II-collagen antibody cocktail (anti-CII) on day &#x02212;3. On day 0 the mice were challenged with mBSA in the right hind paw and with vehicle in the left hind paw. &#x00394;paw swelling on day <italic>x</italic> was calculated by subtracting the baseline measurement made on day 0 prior to challenge from the measurement made on day <italic>x</italic>. <italic>n</italic>=5-35; mean&#x000b1;s.d. shown. (B) T<sub>regs</sub> were defined as live CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> cells, and effector T cells (T<sub>eff</sub>) by inverting the CD25<sup>+</sup>FoxP3<sup>+</sup> gate within the CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup> gate. T<sub>regs</sub> were further gated on the activation marker CD44 and the proliferation marker Ki67. Total numbers of T<sub>regs</sub>, T<sub>eff</sub>, CD44<sup>+</sup> T<sub>regs</sub> and Ki67<sup>+</sup> T<sub>regs</sub> are shown in blood (cells/ml), the popliteal lymph node draining the arthritic paw (dPLN) and the popliteal lymph node draining the control paw (ndPLN). Mean&#x000b1;s.e.m. is shown, <italic>n</italic>=5. (C) <italic>F</italic><italic>oxp3</italic> and <italic>C</italic><italic>tla4</italic> mRNA in arthritic paws measured by mRNA deep sequencing. RPKM, reads per kilobase of transcript per million mapped reads. Mean shown, <italic>n</italic>=4. **<italic>P</italic>&#x02264;0.01, ***<italic>P</italic>&#x02264;0.001, difference to levels on day 0, one-way ANOVA. (D) Total cell counts in the inguinal lymph nodes. T<sub>regs</sub> were defined as live CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>FoxP3<sup>+</sup> cells and T<sub>eff</sub> by inverting the CD25<sup>+</sup>FoxP3<sup>+</sup> gate within the CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup> gate, <italic>n</italic>=6, mean&#x000b1;s.e.m. shown. Student's <italic>t</italic>-test, ***<italic>P</italic>&#x02264;0.001. (E) Representative flow cytometry plots from day 2 post-DTHA induction showing CD25<sup>hi</sup>FoxP3<sup>hi</sup> T<sub>reg</sub> populations (box) in dPLN, ndPLN and blood. Cells were defined as live CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup> before gating on CD25 and FoxP3. The top panel shows FoxP3 staining and the bottom panel staining with IgG2a isotype control antibody. (F) Percentage of CD25<sup>hi</sup>FoxP3<sup>hi</sup> T<sub>regs</sub> in dPLN, ndPLN and blood after induction of DTHA and in na&#x000ef;ve mice. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=3-6. Difference to percentages in na&#x000ef;ve mice analysed using one-way ANOVA, **<italic>P</italic>&#x02264;0.01, ***<italic>P</italic>&#x02264;0.001. (G) Percentage of CD25<sup>hi</sup>FoxP3<sup>hi</sup> T<sub>regs</sub> in dPLN expressing CD44 (left) and Ki67 (right); mean&#x000b1;s.d. shown, <italic>n</italic>=3-6. All experiments presented in this figure were carried out once. Full flow cytometry gating strategy is shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S1A</uri>.</p></caption><graphic xlink:href="dmm-9-022905-g1"/></fig></p></sec><sec id="s2b"><title>Depletion of T<sub>regs</sub> after arthritis induction exacerbates inflammation and leads to a rapid increase in arthritic disease activity</title><p>In order to assess the importance of T<sub>regs</sub> in regulating DTHA severity, we selectively depleted T<sub>regs</sub> by administration of DT at 24 and 48&#x02005;h after arthritis induction to <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mice (FoxP3-DTR<sup>+</sup>) and littermate controls (FoxP3-DTR<sup>&#x02212;</sup>). This resulted in depletion of all eGFP<sup>+</sup> cells in FoxP3-DTR<sup>+</sup> mice as confirmed by flow cytometry (<uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S2</uri>). However, eGFP<sup>+</sup> cells eventually repopulate the T<sub>reg</sub> niche after transient DT treatment, as shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S2</uri>C. Depletion of T<sub>regs</sub> rapidly led to increased paw and ankle swelling, which persisted up to at least day 10 (<xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>A,B). In T<sub>reg</sub>-depleted mice, levels of the acute-phase protein serum amyloid P component (SAP) were elevated in serum on day 10 compared to control mice (<xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>C), as was C-terminal telopeptide of type I collagen (CTX-I; <xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>D), whereas tartrate-resistant acid phosphatase (TRAP) serum levels were not increased (<xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>D). Histopathological analysis on day 10 showed increased infiltration of macrophages into the T<sub>reg</sub>-depleted paws (<xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>E,F). Histological scoring revealed a tendency towards increased bone erosion in T<sub>reg</sub>-depleted mice, whereas there was no difference in cartilage degradation and synovitis (<xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>G). However, inflammation and new bone formation at extra-articular sites were increased in T<sub>reg</sub>-depleted mice, and so was the histopathological sum score (<xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>H). Interestingly, we observed a correlation (<italic>r</italic>=0.5949, <italic>P</italic>=0.0092, <italic>n</italic>=18) between extra-articular inflammation and new bone formation (<xref ref-type="fig" rid="DMM022905F2">Fig.&#x000a0;2</xref>I), indicating that new bone formation in DTHA is an inflammation-associated process.
<fig id="DMM022905F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>Depletion of T<sub>regs</sub> leads to increased disease activity in DTHA.</bold> T<sub>regs</sub> were depleted from mice carrying the <italic>Fox</italic><italic>p3-DTR-eGFP</italic> transgene (FoxP3-DTR<sup>+</sup>) by administration of diphtheria toxin (DT) 24 and 48&#x02005;h after DTHA induction. Non-transgene littermates (FoxP3-DTR<sup>&#x02212;</sup>) were used as controls and also given DT. Paw and ankle swelling shown over the duration of the study (A) and as area under curve (AUC) (B), <italic>n</italic>=8-10, mean&#x000b1;s.e.m. shown. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05; **<italic>P</italic>&#x02264;0.01; ***<italic>P</italic>&#x02264;0.001. (C) Serum levels of serum amyloid P component (SAP) in serum measured 10&#x02005;days after DTHA induction by ELISA, <italic>n</italic>=8-10, mean&#x000b1;s.e.m. shown. Student's <italic>t</italic>-test, **<italic>P</italic>&#x02264;0.01. (D) Serum levels of C-terminal telopeptide of type I collagen (CTX-I) and tartrate-resistant acid phosphatase (TRAP) measured 10&#x02005;days after DTHA induction by ELISA, <italic>n</italic>=8-10, mean&#x000b1;s.e.m. shown. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05. (E) Representative images of immunohistochemistry (IHC) stainings for the macrophage marker F4/80 or the neutrophil marker Ly6B.2. Positively stained cells appear brown. Scale bars: 1&#x02005;mm. (F) Macrophage and neutrophil infiltration quantified by analysing paw sections stained by immunohistochemistry for the macrophage marker F4/80 or the neutrophil marker Ly6B.2 using digitalised image analysis software. Target-cell infiltration was defined as percentage of 3-3&#x02032;-diamino-benzidine-tetrahydrochloride-positive (DAB<sup>+</sup>) area of total paw area. <italic>n</italic>=8-10, mean&#x000b1;s.e.m. shown. Student's <italic>t</italic>-test, **<italic>P</italic>&#x02264;0.01. (G) Semi-quantitative histopathological scoring of arthritic and inflammatory parameters on day 10 using a scale of 0-3 (see Materials and Methods for details), <italic>n</italic>=8-10, mean&#x000b1;s.e.m. shown. Student's <italic>t</italic>-test with Welch's correction, *<italic>P</italic>&#x02264;0.05; **<italic>P</italic>&#x02264;0.01. (H) Sum of the individual scores in G. Maximum possible score is 15. <italic>n</italic>=8-10, mean&#x000b1;s.e.m. shown. Student's <italic>t</italic>-test with Welch's correction, *<italic>P</italic>&#x02264;0.05. (I) Correlation between the histopathological scores for extra-articular inflammation and bone formation in all mice. Slope&#x000b1;95% CI shown, <italic>n</italic>=18 (some points are on top of each other). Spearman <italic>r</italic>=0.5949, <italic>P</italic>=0.0092. Results presented in this figure are representative of two independent experiments.</p></caption><graphic xlink:href="dmm-9-022905-g2"/></fig></p></sec><sec id="s2c"><title>Depletion of T<sub>regs</sub> leads to an increase in biomarkers of arthritis and inflammatory cells in the affected paw and in circulation</title><p>Next, we investigated the mechanisms of the increased arthritis response following T<sub>reg</sub> depletion by sampling on day 4 and 7 post-arthritis induction. We found increased paw swelling in T<sub>reg</sub>-depleted mice (<xref ref-type="fig" rid="DMM022905F3">Fig.&#x000a0;3</xref>A), and increased levels of SAP, IL-6 and matrix metalloproteinase 3 (MMP3) on both day 4 and 7 in T<sub>reg</sub>-depleted mice (<xref ref-type="fig" rid="DMM022905F3">Fig.&#x000a0;3</xref>B). Levels of CTX-I were increased on day 7 but not day 4. Neutrophil chemoattractant granulocyte colony stimulating factor (G-CSF) was increased on day 4, but not day 7 (<xref ref-type="fig" rid="DMM022905F3">Fig.&#x000a0;3</xref>B). Interestingly, we detected production of anti-MCV in DTHA, and, following T<sub>reg</sub> depletion, anti-MCV antibody levels were increased in serum (<xref ref-type="fig" rid="DMM022905F3">Fig.&#x000a0;3</xref>B). In order to investigate whether T<sub>regs</sub> play a role in regulating bone resorption in DTHA, we measured levels of RANKL, osteoprotegerin (OPG) and TRAP in whole paw tissue. We found that levels of both RANKL and TRAP increased in the arthritic paws on day 4 and 7, and the RANKL/OPG ratio increased after T<sub>reg</sub> depletion (<xref ref-type="fig" rid="DMM022905F3">Fig.&#x000a0;3</xref>C). We also investigated the cellular players in the increased inflammatory response after T<sub>reg</sub> depletion. Systemic neutrophilia and increased numbers of neutrophils in inflamed paws and dPLNs were observed (<xref ref-type="fig" rid="DMM022905F4">Fig.&#x000a0;4</xref>A,B). Increased numbers of macrophages in the inflamed paws and dPLNs were also observed (<xref ref-type="fig" rid="DMM022905F4">Fig.&#x000a0;4</xref>B and data not shown). Numbers of CD4<sup>+</sup> T cells in the paw were increased compared to controls on day 7 but not day 4 (<xref ref-type="fig" rid="DMM022905F4">Fig.&#x000a0;4</xref>B), but there was no increase in CD4<sup>+</sup> T cells in the dPLN (<xref ref-type="fig" rid="DMM022905F4">Fig.&#x000a0;4</xref>C). However, CD4<sup>+</sup> T cells in the dPLN were found to be more activated (<xref ref-type="fig" rid="DMM022905F4">Fig.&#x000a0;4</xref>D). Taken together, these data show that depletion of T<sub>regs</sub> increases systemic inflammation, increases the production of autoantibodies, increases bone resorption, increases the numbers of neutrophils and macrophages in the inflamed paw and its draining lymph node, and enhances T-cell activation.
<fig id="DMM022905F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p><bold>Depletion of T<sub>regs</sub> leads to rapidly increased inflammatory and arthritic activity both locally and systemically.</bold> (A) T<sub>regs</sub> were depleted from mice carrying the <italic>Fox</italic><italic>p3-DTR-eGFP</italic> transgene (FoxP3-DTR<sup>+</sup>) by administration of diphtheria toxin (DT) 24 and 48&#x02005;h after DTHA induction. Non-transgene littermates (FoxP3-DTR<sup>&#x02212;</sup>) were used as controls. Paw swelling shown over the duration of the study (left) and as paw weight (right). Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05; ***<italic>P</italic>&#x02264;0.001. (B) Serum levels of matrix metalloproteinase 3 (MMP3), C-terminal telopeptide of type I collagen (CTX-I), IL-6, antibodies to mutated citrullinated vimentin (anti-MCV), granulocyte colony stimulating factor (G-CSF) and serum amyloid P component (SAP) were measured by ELISA in serum on day 4 and 7 post-DTHA induction. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05; **<italic>P</italic>&#x02264;0.01; ***<italic>P</italic>&#x02264;0.001. (C) Levels of receptor-activator of nuclear factor kappa B ligand (RANKL), osteoprotegerin (OPG) and tartrate-resistant acid phosphatase (TRAP) were measured by ELISA in whole paw homogenate supernatants on day 4 and 7 after DTHA induction. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05; **<italic>P</italic>&#x02264;0.01; ***<italic>P</italic>&#x02264;0.001. Dotted line represents mean OPG level in <italic>n</italic>=2 na&#x000ef;ve mice. Results presented in this figure are representative of two independent experiments.</p></caption><graphic xlink:href="dmm-9-022905-g3"/></fig>
<fig id="DMM022905F4" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p><bold>T<sub>reg</sub> depletion in DTHA leads to increased neutrophil recruitment and CD4<sup>+</sup> T-cell activity.</bold> (A) Counts and percentages of neutrophils were analysed in blood and the popliteal lymph node draining the arthritic paw (dPLN) on day 4 and 7 after DTHA induction by flow cytometry. Neutrophils were defined as live CD45<sup>+</sup>CD11b<sup>+</sup>Ly6G<sup>+</sup>. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05; **<italic>P</italic>&#x02264;0.01. (B) Cell counts of total live cells, CD4<sup>+</sup> T cells, macrophages and neutrophils in the arthritic paw analysed on day 4 and 7 after DTHA induction by flow cytometry. CD4<sup>+</sup> T cells and neutrophils defined as before, macrophages defined as live CD45<sup>+</sup>CD11b<sup>+</sup>F4/80<sup>+</sup> cells. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05; **<italic>P</italic>&#x02264;0.01; ***<italic>P</italic>&#x02264;0.001. (C) Counts and percentages of CD4<sup>+</sup> T cells analysed in the dPLN on day 4 and 7 after DTHA induction by flow cytometry. CD4<sup>+</sup> T cells were defined as live CD45<sup>+</sup>TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup> cells. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, **<italic>P</italic>&#x02264;0.01. (D) Median fluorescence intensity (MFI) of CD44-APC (left) and CD62L-PE (right) in the CD4<sup>+</sup> T-cell gate. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, **<italic>P</italic>&#x02264;0.01; ***<italic>P</italic>&#x02264;0.001. Results presented in this figure are representative of two independent experiments. Full flow cytometry gating strategy is shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S1B,C</uri>.</p></caption><graphic xlink:href="dmm-9-022905-g4"/></fig></p></sec><sec id="s2d"><title>Concomitant depletion of T<sub>regs</sub> and blockade of IL-10 signalling increased paw and ankle swelling to an even larger degree than T<sub>reg</sub> depletion or IL-10 blockade alone</title><p>We found that concomitant depletion of T<sub>regs</sub> and blockade of IL-10 signalling increased paw and ankle swelling to an even larger degree than T<sub>reg</sub> depletion or IL-10 blockade alone (<uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S3A-C</uri>). Active bone remodelling on day 10 post-arthritis induction, measured through serum CTX-I, was only detectable in mice with both depleted T<sub>regs</sub> and blocked IL-10R signalling (<uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S3D</uri>).</p></sec><sec id="s2e"><title>Depletion of T<sub>regs</sub> increases bacterial diversity transiently without affecting the overall major taxonomic composition of fecal microbiota</title><p>Fecal samples from the distal colon were collected before DTHA induction on day 0, and on day 4 and 9 following DTHA induction with or without concurrent depletion of T<sub>regs</sub>. The composition of the microbiota was investigated by sequencing of the V4 hypervariable region of the 16S rRNA gene. Principal coordinate analysis (PCoA) at the level of operational taxonomic units (OTUs) revealed no significant changes in overall clustering following DTHA induction (<uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S4</uri>). However, we found that the bacterial composition of the T<sub>reg</sub>-depleted mice was more diverse on day 4 compared to the non-depleted mice (<xref ref-type="fig" rid="DMM022905F5">Fig.&#x000a0;5</xref>A), with a tendency towards an increase in alpha diversity for the T<sub>reg</sub>-depleted mice from day 0 to 4 (<italic>P</italic>=0.141), whereas beta diversity did not differ significantly (<xref ref-type="fig" rid="DMM022905F5">Fig.&#x000a0;5</xref>B). Interestingly, alpha diversity correlated inversely with ankle swelling for the T<sub>reg</sub>-depleted group at day 4 (Spearman's &#x003c1;=&#x02212;0.964; <italic>P</italic>&#x0003c;0.01; <italic>n</italic>=7). Analysis at the phylum level revealed no significant differences between the two groups, or between days within each group (<xref ref-type="fig" rid="DMM022905F5">Fig.&#x000a0;5</xref>C). We detected no significant changes in the relative abundance of genera (<xref ref-type="fig" rid="DMM022905F5">Fig.&#x000a0;5</xref>D) between groups, or between days within each group, although the abundance of <italic>Lactobacillus</italic> tended to be higher on day 4 compared to day 0 and 9 (<italic>P</italic>=0.084 and 0.12 for FoxP3-DTR<sup>+</sup> and <italic>P</italic>=0.229 and 0.305 for FoxP3-DTR<sup>&#x02212;</sup>, respectively). Correlations between taxa abundance and ankle swelling, paw swelling, TRAP, and CTX-I, respectively, did not show high correlation coefficients or patterns of correlations (data not shown). Taken together, these data show that DTHA induction alone or in conjunction with the depletion of T<sub>regs</sub> induce only minor and transient compositional changes in the fecal bacterial microbiota. Thus, contrasting with results obtained by analysis of RA patients (<xref rid="DMM022905C64" ref-type="bibr">Zhang et al., 2015</xref>), no significant arthritis-associated changes in the gut microbiota were detected in the mouse models.
<fig id="DMM022905F5" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p><bold>T<sub>reg</sub> depletion in DTHA has limited effect on the overall composition of the microbiota in the distal colon.</bold> Fecal microbiota was analysed for bacterial 16S rRNA composition. (A) Alpha diversity based on Shannon index of unfiltered data for fecal samples. Median alpha diversity with upper and lower quantiles shown, <italic>n</italic>=7. *<italic>P</italic>&#x02264;0.05. (B) Beta diversity based on Whittaker's species turnover within each group. Median beta diversity with upper and lower quantiles indicated, <italic>n</italic>=7. (C) Taxa summary plot at phylum level showing changes in the microbiota composition of the fecal samples. Mean relative abundance shown, <italic>n</italic>=7. (D) Taxa summary plot at phylum level showing changes in the microbiota composition of the fecal samples. Mean relative abundance shown, <italic>n</italic>=7. Except for beta diversity, Wilcoxon rank-sum for tests between groups and Wilcoxon signed-rank for tests within groups. This experiment was carried out once.</p></caption><graphic xlink:href="dmm-9-022905-g5"/></fig></p></sec><sec id="s2f"><title>Depletion of T<sub>regs</sub> leads to increased production of inflammatory mediators locally in the arthritic paws</title><p>To further elucidate the mechanisms of increased inflammation following T<sub>reg</sub> depletion in DTHA, we measured levels of a range of cytokines and chemokines in whole paw tissue. The cytokines IL1&#x003b2;, IL-17, IL-12(p70), IL-6 and IL-10 were all increased in paw tissue on both day 4 and 7 compared with controls (<xref ref-type="fig" rid="DMM022905F6">Fig.&#x000a0;6</xref>). IFN&#x003b3; was increased only on day 4 and TNF&#x003b1; only on day 7 (<xref ref-type="fig" rid="DMM022905F6">Fig.&#x000a0;6</xref>). The chemokines CCL2 (MCP-1), CXCL10 (IP-10), CXCL5 (LIX), CCL5 (RANTES) and CXCL9 (MIG) were all increased in paw tissue on both day 4 and 7 compared with controls (<xref ref-type="fig" rid="DMM022905F6">Fig.&#x000a0;6</xref>). CXCL2 (MIP-2), CCL3 (MIP-1&#x003b1;) and CXCL1 (KC) were increased only on day 7 and tended to increase on day 4 (<xref ref-type="fig" rid="DMM022905F6">Fig.&#x000a0;6</xref>). Levels of G-CSF were increased in paw tissue on day 7 and tended to increase on day 4 (<xref ref-type="fig" rid="DMM022905F6">Fig.&#x000a0;6</xref>). Granulocyte-macrophage colony-stimulating factor (GM-CSF) was increased in paw tissue both on day 4 and 7 after DTHA induction (<xref ref-type="fig" rid="DMM022905F6">Fig.&#x000a0;6</xref>). Taken together, these data show a profile of inflammatory mediators that both favours and is a result of Th17 T-cell polarisation, T-cell infiltration and activation, and neutrophil and macrophage infiltration and activation.
<fig id="DMM022905F6" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p><bold>Depletion of T<sub>regs</sub> augments production of inflammatory mediators locally in the affected paws.</bold> Whole paw homogenate supernatants were analysed for protein levels (pg/g tissue) of a range of inflammatory markers using multiplex analysis. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. Student's <italic>t</italic>-test, *<italic>P</italic>&#x02264;0.05; **<italic>P</italic>&#x02264;0.01; ***<italic>P</italic>&#x02264;0.001. <italic>P</italic>-values were corrected for mass significance using the False Discovery Rate method. The raw and corrected <italic>P</italic>-values are shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Table&#x000a0;S1</uri>. MCP, monocyte chemoattractant protein; CCL, CC chemokine ligand; MIP, macrophage inflammatory protein; CXCL, CXC chemokine ligand; IP, interferon gamma-induced protein; MIG, monokine induced by gamma interferon; RANTES, regulated on activation, normal T cell expressed and secreted; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor. Results presented in this figure are representative of two independent experiments.</p></caption><graphic xlink:href="dmm-9-022905-g6"/></fig></p></sec><sec id="s2g"><title>Treatment with anti-IL-17 mAb rescues mice from exacerbation of disease caused by depletion of T<sub>regs</sub></title><p>Based on our findings so far, we hypothesised that IL-17 could play a part in the increased disease activity observed following T<sub>reg</sub> depletion. To test this, we set up a study where T<sub>reg</sub>-depleted mice were also treated with anti-IL-17 mAb. We found that anti-IL-17 treatment reduced paw swelling in mice both with and without intact T<sub>reg</sub> compartments (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>A). We also found that anti-IL-17 treatment of T<sub>reg</sub>-depleted mice reduced paw swelling to levels seen in isotype-treated, non-T<sub>reg</sub>-depleted mice, thus rescuing them from the exacerbated disease caused by the depletion of T<sub>regs</sub> (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>A). Starting anti-IL-17 treatment at immunisation (<uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S5</uri>) did not reduce paw swelling to a greater degree than anti-IL-17 treatment begun at the time of arthritis induction (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>A). Anti-IL-17 treatment did not have an effect on the production of anti-MCV (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>B). There was a tendency towards reduced myeloperoxidase (MPO) levels in anti-IL-17-treated mice both with and without intact T<sub>reg</sub> compartments, compared with isotype-control-treated animals (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>C). In addition, neutrophil numbers in circulation were reduced after IL-17 blockade in mice both with and without an intact T<sub>reg</sub> compartment (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>D). We found that blockade of IL-17 reduced levels of IL-6, CXCL1, CXCL5 and G-CSF in arthritic paws of mice with intact T<sub>reg</sub> compartments and tended to reduce IL-6 and CXCL1 in mice depleted of T<sub>regs</sub> (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>E). IL-17 blockade reduced the levels of IL-6 and CXCL1 in mice that received T<sub>reg</sub> depletion+anti-IL-17 to levels seen in non-T<sub>reg</sub>-depleted+isotype-treated mice (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>E). Importantly, anti-IL-17 treatment reduced levels of RANKL in paw tissue in mice both with and without intact T<sub>reg</sub> compartments (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>F). In line with this, there was a tendency towards a reduction of TRAP levels after IL-17 blockade. T<sub>reg</sub> depletion reduced the RANKL/OPG ratio and IL-17 blockade increased the RANKL/OPG ratio, indicating that T<sub>reg</sub> depletion favours a more resorptive state, whereas IL-17 blockade reverses the effect of T<sub>reg</sub> depletion on bone erosion (<xref ref-type="fig" rid="DMM022905F7">Fig.&#x000a0;7</xref>F). In summary, we find that IL-17 blockade rescues mice from the increased disease activity observed after T<sub>reg</sub> depletion, and does so through a reduction in neutrophil numbers and local IL-6, CXCL1 and RANKL levels.
<fig id="DMM022905F7" orientation="portrait" position="float"><label>Fig. 7.</label><caption><p><bold>Treatment with anti-IL-17 rescues mice from exacerbated disease caused by T<sub>reg</sub> depletion.</bold> (A) Anti-IL-17 treatment was initiated at the time of arthritis induction 1 day prior to T<sub>reg</sub> depletion and given every 48&#x02005;h until experiment termination on day 7. Left graph: paw swelling day 0-7. Right graph: area under curve (AUC) of paw swelling day 0-7. ns, not significant, *<italic>P</italic>&#x02264;0.05, ***<italic>P</italic>&#x02264;0.001. (B) Levels of anti-mutated-citrullinated-vimentin (MCV) antibodies in serum measured by ELISA as optical density (OD). Dotted line represents levels in <italic>n</italic>=5 na&#x000ef;ve mice. (C) Levels of myeloperoxidase (MPO) in paw tissue measured by ELISA of whole paw homogenate supernatants. (D) Neutrophils/ml blood measured by flow cytometry. Neutrophils were defined as live CD45<sup>+</sup>TCR&#x003b2;<sup>&#x02212;</sup>CD11b<sup>+</sup>Ly6G<sup>+</sup> cells. ns, not significant, *<italic>P</italic>&#x02264;0.05. (E) Analysis of inflammatory mediators in whole paw homogenate supernatants from T<sub>reg</sub>-depleted mice (blue bars) and non-depleted mice (black bars) treated with anti-IL-17 mAb or isotype control, using multiplex analysis [IL-1&#x003b2;, TNF&#x003b1;, IFN&#x003b3;, IL-6, IL-10, IL-12(p70), MIP-2 (CXCL2), IP-10 (CXCL10), LIX (CXCL5), RANTES (CCL5), MIG (CXCL9), MIP-1&#x003b1; (CCL3), KC (CXCL1), G-CSF and GM-CSF] and ELISA (IL-23). Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. ns, not significant, *<italic>P</italic>&#x02264;0.05, Student's <italic>t</italic>-test. <italic>P</italic>-values were corrected for mass significance using the False Discovery Rate method. The raw and corrected <italic>P</italic>-values are shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Table&#x000a0;S1</uri>. This experiment was carried out once. (F) Levels of RANKL, OPG and TRAP were measured in whole paw homogenate supernatants from T<sub>reg</sub>-depleted mice (blue) and non-depleted mice (black) treated with anti-IL-17 mAb or isotype control, using ELISA. Mean&#x000b1;s.e.m. shown, <italic>n</italic>=10. ns, not significant, *<italic>P</italic>&#x02264;0.05. Dotted line represents mean OPG level in <italic>n</italic>=2 na&#x000ef;ve mice. CCL, CC chemokine ligand; MIP, macrophage inflammatory protein; CXCL, CXC chemokine ligand; IP, interferon gamma-induced protein; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; MIG, monokine induced by gamma interferon; OPG, osteoprotegerin; RANKL, receptor-activator of nuclear factor &#x003ba;B ligand; RANTES, regulated on activation, normal T cell expressed and secreted; TRAP, tartrate-resistant acid phosphatase.</p></caption><graphic xlink:href="dmm-9-022905-g7"/></fig></p></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>In RA, dysregulation of the T<sub>reg</sub> compartment has been reported, and T<sub>reg</sub> numbers and levels of IL-17 expression correlate with disease severity (<xref rid="DMM022905C44" ref-type="bibr">Noack and Miossec, 2014</xref>; <xref rid="DMM022905C63" ref-type="bibr">Zaiss et al., 2010</xref>). Different approaches to tipping the T<sub>eff</sub>/T<sub>reg</sub> balance towards T<sub>reg</sub> dominance have been put forward as potential therapeutic strategies in RA and other inflammatory diseases; however, none have yet been fully successful (<xref rid="DMM022905C41" ref-type="bibr">Miyara et al., 2014</xref>). Knowledge of the roles played by T<sub>regs</sub> in experimental arthritis models is instrumental for the development of safe and effective therapeutic strategies involving T<sub>regs</sub> in humans. In this study, we investigated the kinetics of T<sub>regs</sub> in DTHA and characterised the exacerbated inflammatory response that resulted from selective depletion of T<sub>regs</sub>. To our knowledge, this is the first study to characterise the mechanisms of exacerbated disease in an arthritis model following depletion of T<sub>regs</sub> using <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mice. Transient DT treatment, although sufficient to give the desired biological effect in many cases, can also leave a residual number of eGFP<sup>+</sup> FoxP3<sup>+</sup> cells, and these cells eventually repopulate the T<sub>reg</sub> niche (<xref rid="DMM022905C29" ref-type="bibr">Lahl et al., 2007</xref>; <xref rid="DMM022905C28" ref-type="bibr">Lahl and Sparwasser, 2011</xref>). However, because we were interested in examining the effects of T<sub>reg</sub> depletion on inflammation in the early stages of DTHA, our assessment was that this mouse was suitable for our purpose, despite its limitations.</p><p>T<sub>reg</sub> numbers in DTHA expanded rapidly and these cells were found to be highly activated and proliferating in lymphoid and paw tissue. This indicates that T<sub>regs</sub> are important in the early stages of DTHA. However, the fact that we observed severe inflammation in the affected paw despite the expansion of T<sub>regs</sub> could be the result of a dysregulation of the Th17/T<sub>reg</sub> balance, because increased Th17 activity is also seen in the early stages of DTHA (<xref rid="DMM022905C3" ref-type="bibr">Atkinson et al., 2012</xref>). In support of this, we also show in the present study that neutralisation of IL-17 reduced severity of disease and could prevent the detrimental effects of T<sub>reg</sub> depletion in the model.</p><p>Selective T<sub>reg</sub> depletion increased arthritis severity, and the observed correlation between paw inflammation and new bone formation indicated that new bone formation could be linked to inflammation in DTHA. In support of this, we have previously shown that suppression of inflammation in DTHA with anti-TNF&#x003b1; antibodies (<xref rid="DMM022905C3" ref-type="bibr">Atkinson et al., 2012</xref>) or anti-C5aR antibodies (<xref rid="DMM022905C4" ref-type="bibr">Atkinson et al., 2015</xref>) could reduce bone formation. Inflammation has also been linked to bone formation in the CIA, proteoglycan-induced arthritis (PGIA) and SKG inflammatory arthritis models (<xref rid="DMM022905C6" ref-type="bibr">Denninger et al., 2015</xref>; <xref rid="DMM022905C52" ref-type="bibr">Schett et al., 2009</xref>; <xref rid="DMM022905C18" ref-type="bibr">Haynes et al., 2012</xref>; <xref rid="DMM022905C26" ref-type="bibr">Keller et al., 2012</xref>), and in ankylosing spondylitis (<xref rid="DMM022905C37" ref-type="bibr">Maksymowych et al., 2013</xref>; <xref rid="DMM022905C59" ref-type="bibr">Wanders et al., 2005</xref>). However, T<sub>reg</sub> depletion also led to increased bone resorption in DTHA in the present study. The presence of these two opposing phenotypes can seem counterintuitive, but the bone formation and bone erosion take place at different areas of the paw (<xref rid="DMM022905C3" ref-type="bibr">Atkinson et al., 2012</xref>), and simultaneous bone erosion and bone formation has also been observed in the CIA model in a recent study (<xref rid="DMM022905C6" ref-type="bibr">Denninger et al., 2015</xref>). The net effect, however, is a negative association between inflammation and bone mass, as previously described (<xref rid="DMM022905C14" ref-type="bibr">Gilbert et al., 2013</xref>; <xref rid="DMM022905C49" ref-type="bibr">Proulx et al., 2007</xref>; <xref rid="DMM022905C58" ref-type="bibr">Walsh et al., 2005</xref>).</p><p>Depletion of T<sub>regs</sub> led to increased CD4<sup>+</sup> T-cell activation and to increased recruitment of CD4<sup>+</sup> T cells to the site of inflammation. This shows that the control of T<sub>eff</sub> activation in the dPLN and T<sub>eff</sub> numbers in the paw is one of the mechanisms of T<sub>reg</sub>-mediated suppression of DTHA. We also observed increased levels of anti-MCV, demonstrating an augmented immune response to a citrullinated self-antigen. Anti-MCV antibodies and other anti-citrullinated protein antibodies (ACPAs) are used as prognostic biomarkers of disease and joint erosion in RA, and ACPA levels correlate with serum CTX-I in RA patients (<xref rid="DMM022905C16" ref-type="bibr">Gudmann et al., 2015</xref>; <xref rid="DMM022905C23" ref-type="bibr">Jilani and Mackworth-Young, 2015</xref>). The fact that we observe a break of self-tolerance to MCV in DTHA and that anti-MCV levels increase with increased disease severity adds to the strengths of DTHA as a model of RA. However, the current study did not address which, if any, role anti-MCV plays in the pathogenesis of DTHA.</p><p>Previous studies have shown that T<sub>regs</sub> are able to limit the accumulation of Th17 cells at inflammatory sites and draining lymph nodes (<xref rid="DMM022905C33" ref-type="bibr">Lohr et al., 2006</xref>). Increased IL-17 production was observed in the T<sub>reg</sub>-depleted mice in the present study. This is supported by the observed increase in production of IL-6, IL-23 and IL-1&#x003b2;, which are cytokines that favour Th17 polarisation (<xref rid="DMM022905C36" ref-type="bibr">Lubberts et al., 2005</xref>; <xref rid="DMM022905C54" ref-type="bibr">Sonderegger et al., 2008</xref>; <xref rid="DMM022905C55" ref-type="bibr">Sutton et al., 2006</xref>). IL-17 is an important cytokine in experimental arthritis when T cells play a part in the pathogenesis (<xref rid="DMM022905C3" ref-type="bibr">Atkinson et al., 2012</xref>; <xref rid="DMM022905C36" ref-type="bibr">Lubberts et al., 2005</xref>). Blockade of IL-17 has previously been shown to ameliorate experimental arthritis and is also a promising therapeutic avenue in RA (<xref rid="DMM022905C34" ref-type="bibr">Lubberts et al., 2001</xref><xref rid="DMM022905C35" ref-type="bibr">, 2004</xref>; <xref rid="DMM022905C48" ref-type="bibr">P&#x000f6;llinger et al., 2011</xref>; <xref rid="DMM022905C57" ref-type="bibr">van den Berg and McInnes, 2013</xref>). We found that treatment with anti-IL-17 could attenuate disease in DTHA, and the results indicate that IL-17 is more important for DTHA pathogenesis after the antigen challenge. The increased IL-17 production after T<sub>reg</sub> depletion could also contribute to the increased bone erosion observed, and results from other studies support this. IL-17 induces osteoclastogenesis from human monocytes in the absence of RANKL (<xref rid="DMM022905C62" ref-type="bibr">Yago et al., 2009</xref>) and upregulates RANKL expression (<xref rid="DMM022905C15" ref-type="bibr">Gizinski and Fox, 2014</xref>), and blocking IL-17 prevents joint destruction in CIA through an increased RANKL/OPG ratio (<xref rid="DMM022905C35" ref-type="bibr">Lubberts et al., 2004</xref>). Our results thus suggest that the increase in bone erosion could be driven by an increase in the RANKL/OPG ratio driven by increased IL-17 activity.</p><p>We observed increased IL-10 production in arthritic paws after T<sub>reg</sub> depletion, which suggests that the contribution of IL-10 by T<sub>regs</sub> to immunoregulation in DTHA is negligible. In a study in which T<sub>regs</sub> were depleted using anti-CD25 mAb, we found that concomitant blockade of IL-10 signalling increased paw and ankle swelling to an even larger degree than T<sub>reg</sub> depletion or IL-10 blockade alone. In the absence of T<sub>regs</sub>, regulatory B cells and their release of IL-10 could represent a compensatory regulatory pathway. B-cell-derived IL-10 has been shown to regulate inflammation in other mouse models (<xref rid="DMM022905C11" ref-type="bibr">Fillatreau et al., 2002</xref>; <xref rid="DMM022905C38" ref-type="bibr">Mauri et al., 2003</xref>; <xref rid="DMM022905C42" ref-type="bibr">Mizoguchi et al., 1997</xref>). In experimental autoimmune encephalitis (EAE), components from <italic>Mycobacterium tuberculosis</italic> in the complete Freund's adjuvant (CFA) that is used to induce disease provide Toll-like receptor (TLR) agonists that can trigger regulatory functions of B cells that are required for the resolution of EAE (<xref rid="DMM022905C31" ref-type="bibr">Lampropoulou et al., 2008</xref>).</p><p>Because B cells are not required for the induction of DTHA (<xref rid="DMM022905C56" ref-type="bibr">Tanaka et al., 2007</xref>) and because CFA containing <italic>M.</italic>
<italic>tuberculosis</italic> is also used for induction, it could be speculated that B cells indeed play an immunoregulatory role in DTHA and that depletion of B cells on top of T<sub>reg</sub> depletion would further exacerbate DTHA.</p><p>We also observed an increased number of neutrophils in paws, dPLNs and blood as well as increased production of granulopoietic factors and neutrophil chemoattractants after T<sub>reg</sub> depletion. This could in part be driven by the increased IL-17 production, because IL-17 is known to stimulate neutrophil recruitment through induction of G-CSF, GM-CSF and chemoattractants, including CXCL1 (<xref rid="DMM022905C17" ref-type="bibr">Hamilton, 2008</xref>; <xref rid="DMM022905C27" ref-type="bibr">Kolls and Lind&#x000e9;n, 2004</xref>; <xref rid="DMM022905C46" ref-type="bibr">Park et al., 2005</xref>; <xref rid="DMM022905C53" ref-type="bibr">Schwarzenberger et al., 2000</xref>). Increased levels of CXCL1 and CXCL2 at the site of inflammation have also previously been shown to result from T<sub>reg</sub> depletion in mice (<xref rid="DMM022905C50" ref-type="bibr">Richards et al., 2010</xref>). Indeed, blockade of IL-17 reduced neutrophil numbers in T<sub>reg</sub>-depleted mice and reduced levels of CXCL1. IL-6 production can be induced by IL-17 (<xref rid="DMM022905C27" ref-type="bibr">Kolls and Lind&#x000e9;n, 2004</xref>) and, in line with this, we observed a major decrease of IL-6 production following IL-17 blockade. IL-6 plays an important role in neutrophil trafficking (<xref rid="DMM022905C10" ref-type="bibr">Fielding et al., 2008</xref>; <xref rid="DMM022905C30" ref-type="bibr">Lally et al., 2005</xref>), so the observed decrease in blood neutrophil numbers after IL-17 blockade could be a result of the decreased IL-6 levels. Taken together, these data support a regulatory role for IL-17 in neutrophil recruitment through IL-6 and CXCL1.</p><p>Recent findings have suggested an association between the gut microbiota and RA (<xref rid="DMM022905C51" ref-type="bibr">Scher et al., 2013</xref>; <xref rid="DMM022905C64" ref-type="bibr">Zhang et al., 2015</xref>), and interactions between the gut microbiota and immune function, including T<sub>regs</sub>, neutrophils and IL-17, are well established (<xref rid="DMM022905C39" ref-type="bibr">Maynard et al., 2012</xref>). However, in our model, depletion of T<sub>regs</sub> did not significantly change the bacterial composition, indicating that immune-driven changes in the gut microbiota are unlikely to play an important role in disease progression in our model. We observed a tendency towards higher alpha diversity in T<sub>reg</sub>-depleted mice and that alpha diversity correlated inversely with ankle size at day 4. Interestingly, we observed a tendency towards an increased abundance of <italic>Lactobacillus</italic> on day 4, which also correlated with maximal ankle swelling. <italic>Lactobacillus</italic> has been shown to be over-represented in RA patients compared to healthy subjects (<xref rid="DMM022905C32" ref-type="bibr">Liu et al., 2013</xref>; <xref rid="DMM022905C64" ref-type="bibr">Zhang et al., 2015</xref>), and the abundance of <italic>Lactobacillus</italic> was also shown to correlate with disease activity in RA patients. Furthermore, mono-colonisation with <italic>Lactobacillus bifidus</italic> was shown to be sufficient for inducing joint inflammation in a mouse model of spontaneous arthritis via TLR2- and TLR4-dependent signalling affecting the balance between T<sub>reg</sub>, Th17 and Th1 in the gut (<xref rid="DMM022905C1" ref-type="bibr">Abdollahi-Roodsaz et al., 2008</xref>). When comparing the microbial changes observed in laboratory animals to humans, it is important to consider the marked environmental differences. Moreover, in DTHA, severe disease is observed after just a few days, whereas RA develops over several years. Although the composition of the microbiota can change within days, the short duration of the model might not be sufficient to markedly affect the composition of the gut microbiota in a manner that reflects the situation in human disease pathogenesis. Nevertheless, the findings suggest a link between <italic>Lactobacillus</italic> and joint inflammation both in rodent models and RA patients.</p><sec id="s3a"><title>Conclusion</title><p>Taken together, our findings show that T<sub>regs</sub> are important for the containment of inflammation in DTHA, and that T<sub>reg</sub> depletion in DTHA acts, at least partly, through increasing IL-17 and RANKL activity and through increasing numbers of neutrophils in blood, dPLNs and paws. We show that IL-17 drives an increase in inflammation in the absence of T<sub>regs</sub>: administration of anti-IL-17 mAb just prior to T<sub>reg</sub> depletion rescues mice from the exacerbation of disease associated with T<sub>reg</sub> depletion through a reduction in IL-6 and CXCL1 production, reduced neutrophil numbers and a reduction in the RANKL/OPG ratio. Thus, an imbalance in the T<sub>reg</sub> and Th17 relationship could be a driver of inflammation in DTHA. To our knowledge, this is the first study using the <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mouse on a C57BL/6 (B6) background for T<sub>reg</sub> depletion in an arthritis model, and we here demonstrate the usefulness of the approach and build upon the already existing body of work in this new model. Many genetically modified mice are bred on a B6 background, and can thus be combined with the <italic>Foxp3-DTR-eGFP</italic> C57BL/6 mouse, making possible the study of T<sub>reg</sub> depletion in concert with the absence/overexpression of proteins relevant for disease pathways. However, the limitations of the <italic>Foxp3-DTR-eGFP</italic> mouse generated by BAC transgenesis must be kept in mind when choosing this model system. Given the relevance of T<sub>regs</sub> in RA and the possibility of developing T<sub>reg</sub>-mediated therapies for RA, using this approach for selective depletion of T<sub>regs</sub> could yield important results to help understand the diverse roles of T<sub>regs</sub> in RA and other inflammatory diseases.</p></sec></sec><sec sec-type="methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4a"><title>Mice</title><p>Female C57BL/6J mice were purchased from Taconic, Ry, Denmark. Female <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mice were generated as described in <xref rid="DMM022905C29" ref-type="bibr">Lahl et al. (2007</xref>), and bred and maintained at Forschungseinrichtungen f&#x000fc;r Experimentelle Medizin, Charit&#x000e9; Universit&#x000e4;tsmedizin Berlin or purchased from Jackson Laboratories (Bar Harbor, ME) on a NOD background (generated as described in <xref rid="DMM022905C9" ref-type="bibr">Feuerer et al., 2009</xref>) and backcrossed for at least eight generations onto the C57BL/6 background at Taconic, Ry, Denmark. <italic>Fox</italic><italic>p3-DTR-eGFP</italic> mice express a fusion protein consisting of the diphtheria toxin (DT) receptor (DTR) and enhanced green fluorescent protein (eGFP) under the control of the <italic>Fox</italic><italic>p3</italic> gene locus inserted by BAC transgenesis. This construct allows selective depletion of T<sub>regs</sub> by DT injection. Animals were housed in a facility with a 12-h light/dark cycle and with free access to water and standard rodent chow (Altromin<sup>&#x000ae;</sup>). All animal experiments performed in Germany were in accordance with the guideline 2010/63/EU from the European Union and the European Convention for the protection of vertebrate animals used for experimental and other scientific purposes. Animal protocols were approved by the ethics committee and the Berlin state authorities (LAGeSo registration # G0331/08). All animal experiments performed in Denmark were conducted according to Danish legislation and have been approved by the Danish Animal Inspectorate and the Novo Nordisk ethical review board.</p></sec><sec id="s4b"><title>Induction and assessment of DTHA</title><p>Mice were anaesthetised by isoflurane/O<sub>2</sub>/N<sub>2</sub>O and immunised intradermally (i.d.) with methylated bovine serum albumin (mBSA) (Sigma, St Louis, MO) emulsified in complete Freund's adjuvant (CFA) (Difco, Detroit, MI) at the tail base. Four days later mice were given 1000&#x02005;&#x000b5;g (approx. 50&#x02005;mg/kg body weight) anti-mouse type II collagen antibody (anti-CII) cocktail (Chondrex, Redmond, WA) containing the clones A2-10 (IgG2a), F10-21 (IgG2a), D8-6 (IgG2a), D1-2G (IgG2b) and D2-112 (IgG2b) intravenously in 200&#x02005;&#x000b5;l phosphate-buffered saline (PBS). Seven days after immunisation the mice were challenged with 200&#x02005;&#x000b5;g mBSA subcutaneously in 20&#x02005;&#x003bc;l PBS in the right foot pad. The left foot pad was given 20&#x02005;&#x003bc;l PBS only and served as control. Baseline paw and ankle measurements were made on the right paw on day 0 prior to mBSA challenge. Paw and ankle swelling was measured using a dial thickness gauge (Mitutoyo, Japan), and was calculated as right paw or ankle thickness minus baseline measurement.</p></sec><sec id="s4c"><title>Depletion of T<sub>regs</sub></title><p>Mice were injected intraperitoneally with 1&#x02005;&#x000b5;g DT (Merck, Darmstadt, Germany) in 100&#x02005;&#x000b5;l PBS 24 and 48&#x02005;h after DTHA induction. Depletion of T<sub>regs</sub> was confirmed by flow cytometry on whole blood sampled 24&#x02005;h after the final DT dose (<uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S1</uri> shows a representative depletion check). Cells were gated on TCR&#x003b2;, CD4 and CD25 and analysed for expression of eGFP. Antibodies used were anti-CD16/32 (BD Biosciences, NJ) for blocking of unspecific Fc-receptor binding, anti-TCR&#x003b2;-PerCP-Cy5.5, clone H57-597 (eBioscience, San Diego, CA), anti-CD25-APC, clone PC61.5 (eBioscience, San Diego, CA), anti-CD4-PE-Cy7, clone RM4-5 (BD Biosciences, NJ) or anti-CD4-Qdot605 (Invitrogen, Carlsbad, CA).</p></sec><sec id="s4d"><title>Depletion of T<sub>regs</sub> and IL-10R blockade</title><p>For depletion of T<sub>regs</sub>, mice were dosed with 200&#x02005;&#x000b5;g rat anti-mouse CD25 mAb (clone PC.61, BioXcell, West Lebanon, NH) or rat IgG1 anti-trinitrophenol (TNP) isotype control (Novo Nordisk A/S, M&#x000e5;l&#x000f8;v, Denmark) 11 and 8&#x02005;days prior to immunisation. For blockade of IL-10R, mice were dosed with 250&#x02005;&#x000b5;g rat anti-mouse IL-10R mAb (clone 1B1.3A, BioXcell, West Lebanon, NH) or rat IgG1 anti-TNP isotype control (Novo Nordisk A/S, M&#x000e5;l&#x000f8;v, Denmark) three times weekly from the time of immunisation. Depletion of T<sub>regs</sub> was confirmed by flow cytometry on whole blood samples drawn 48&#x02005;h after the second dose of anti-CD25. Mouse regulatory T cell staining kit (eBioscience, San Diego, CA) was used. Antibodies used were CD45-PerCP, CD4-APC and CD25-FITC all from BD Biosciences (NJ), and FoxP3-PE (eBioscience, San Diego, CA).</p></sec><sec id="s4e"><title>Anti-IL-17 mAb treatment</title><p>Mice were treated with 400&#x02005;&#x000b5;g rat anti-mouse IL-17 mAb (clone 17F3, BioXcell, West Lebanon, NH) or rat IgG1 isotype control (clone MOPC-21, BioXcell, West Lebanon, NH) in 200&#x02005;&#x000b5;l PBS on the day of arthritis induction and with 200&#x02005;&#x000b5;g rat anti-mouse IL-17 mAb or isotype control in PBS after 48&#x02005;h and every 48&#x02005;h until the experiment was terminated on day 7. For results presented in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S4</uri>, mice were dosed with 200&#x02005;&#x000b5;g rat anti-mouse IL-17 mAb (clone 17F3, BioXcell, West Lebanon, NH) or rat IgG1 isotype control (clone MOPC-21, BioXcell, West Lebanon, NH) in 200&#x02005;&#x000b5;l PBS from the time of immunisation and every 48&#x02005;h until study termination.</p></sec><sec id="s4f"><title>Histopathology</title><p>Paws were processed and stained with hematoxylin and eosin (H&#x00026;E), Safranin O and for tartrate-resistant acid phosphatase (TRAP) as previously described (<xref rid="DMM022905C3" ref-type="bibr">Atkinson et al., 2012</xref>). TRAP stains osteoclasts red, and Safranin O stains cartilage red. The intensity of Safranin O staining is directly proportional to the proteoglycan content in cartilage. Pathological changes in the paws were assessed on H&#x00026;E-, TRAP- and Safranin-O-stained sections. The extra-articular infiltration of inflammatory cells (assessed on a scale of 0-3) and arthritic changes were assessed separately. Arthritic changes were assessed on metatarsal and tarsal joints as synovitis, cartilage destruction and bone erosion, and scored separately on a 0-3 scale. For each of the three parameters of arthritic changes, an average between the two joint areas was calculated. In addition, new bone formation and extra-articular infiltration overall in the paw was scored on a 0-3 scale. New bone formation was defined as the presence of osteophytes, as described in <xref rid="DMM022905C3" ref-type="bibr">Atkinson et al. (2012</xref>). The histology sum score was calculated by adding the five scores (extra-articular infiltration, synovitis, cartilage destruction, bone erosion and bone formation), whereas the extra-articular infiltration score is left out in the arthritis score. The person who performed the evaluation was blinded to the experimental setup.</p></sec><sec id="s4g"><title>Immunohistochemistry and digitalised image analysis</title><p>Immunohistochemical (IHC) detection of macrophages and neutrophils in the paws was performed as previously described (<xref rid="DMM022905C4" ref-type="bibr">Atkinson et al., 2015</xref>). The sections were all digitally scanned and studied using a NanoZoomer Digital Pathology Virtual Slide Viewer (Hamamatsu Photonic, Shizuoka, Japan). Automated digital image analyses of the infiltrating macrophages (F4/80<sup>+</sup>) and neutrophils (Ly6B.2<sup>+</sup>) in the paws were performed using the Visiopharm Integrator System (VIS; version 4.2.2.0, Visiopharm, Hoersholm, Denmark). On individual digital images of the arthritic paw a region-of-interest (ROI) was automatically defined of the entire paw. The bone marrow was outlined manually and excluded from analysis, as was hair follicles and artefacts. Next, an analysis was run inside the ROI to detect the brown DAB (3-3&#x02032;-diamino-benzidine-tetrahydrochloride) staining of the target cells. The results are given as percentage of tissue area positive for F4/80 or Ly6B.2 of the entire paw area.</p></sec><sec id="s4h"><title>Flow cytometry</title><p>Single-cell suspensions of blood, popliteal lymph nodes and paw infiltrate were prepared as previously described (<xref rid="DMM022905C3" ref-type="bibr">Atkinson et al., 2012</xref>). All samples were subjected to Fc-blocking prior to antibody staining using anti-CD16/32 (BD Biosciences, NJ). Dead cells were excluded using Fixable Near-IR Vital dye (Invitrogen, Carlsbad, CA). Antibodies used were anti-CD45-V500 (clone 30-F11, BD Biosciences, NJ), anti-CD45-eFluor450 (clone 30-F11, eBioscience, San Diego, CA), anti-TCR&#x003b2;-PerCP-Cy5.5 (clone H57-597, eBioscience, San Diego, CA), anti-TCR&#x003b2;-Qdot655 (clone H57-597, Molecular Probes, Carlsbad, CA) anti-CD4-PE-Cy7 (clone RM4-5, BD Biosciences, NJ), anti-CD4-Qdot605 (clone RM4-5, Invitrogen, Carlsbad, CA), anti-CD19-FITC (clone 1D3 eBioscience, San Diego, CA), anti-CD62L-PE (clone MEL-14, eBioscience, San Diego, CA), anti-CD44-APC (clone IM7, eBioscience, San Diego, CA), anti-CD8a-Pacific Blue (clone 53-6.7, Biolegend, San Diego, CA), anti-F4/80-eFluor450 (clone BM8, eBioscience, San Diego, CA), anti-Ly6.G-PE (clone 1A8, BD Biosciences, NJ) and anti-CD11b-APC (clone M1/70, eBioscience, San Diego, CA). Samples were run on an LSRII or FACSCanto flow cytometer and data were analysed using FACSDiva software (BD Biosciences, NJ). All cells were gated on live/dead marker and CD45 before further analysis. Neutrophils were defined as CD11b<sup>+</sup>Ly6G<sup>+</sup>, macrophages as CD11b<sup>+</sup>F4/80<sup>+</sup>, T cells as TCR&#x003b2;<sup>+</sup>, and CD4 and CD8 T cells as TCR&#x003b2;<sup>+</sup>CD4<sup>+</sup> and TCR&#x003b2;<sup>+</sup>CD8<sup>+</sup>, respectively. Full gating strategies for the individual experiments are shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Fig.&#x000a0;S1</uri>.</p></sec><sec id="s4i"><title>Multiplex analysis of inflammatory markers in paw homogenate</title><p>Hind paws were sampled at selected times after DTHA induction and each paw was placed in 1.25&#x02005;ml of an ice-cold custom-made homogenization buffer containing a solution of 200&#x02005;mM NaCl, 5&#x02005;mM EDTA, 10&#x02005;mM Tris, 10% glycerin, 1&#x02005;mM phenylmethylsulfonyl fluoride (PMSF), 1&#x02005;mg/ml leupeptin and 28&#x02005;mg/ml aprotinin with a pH value of 7.4 (Ampliqon, Skovlunde, Denmark). The paws were homogenized by using a T25 Ultraturrax homogeniser (IKA, Staufen, Germany) followed by centrifugation at 10,000&#x02005;<bold><italic>g</italic></bold> for 15&#x02005;min. The supernatants were decanted and centrifuged once more at 10,000&#x02005;<bold><italic>g</italic></bold> for 15&#x02005;min. The final supernatants were analysed undiluted for levels of IL-1&#x003b2;, TNF&#x003b1;, IFN&#x003b3;, IL-6, IL-10, IL-17, IL-12(p40), MIP-2 (CXCL2), IP-10 (CXCL10), LIX (CXCL5), RANTES (CCL5), MIG (CXCL9), MIP-1&#x003b1; (CCL3), KC (CXCL1), MCP-1 (CCL2), G-CSF and GM-CSF using bead-based Luminex<sup>&#x000ae;</sup> xMAP<sup>&#x000ae;</sup> technology with Milliplex kits from Millipore (Billerica, MA) according to the manufacturer's instructions. For statistical analysis, any values below the detection limit were set to the detection limit for the analyte in question and any values above the detection limit were set to the upper detection limit for the analyte in question.</p></sec><sec id="s4j"><title>Enzyme-linked immunosorbent assays (ELISAs)</title><p>Levels of serum amyloid P component (SAP) were measured in serum using kits from Genway (San Diego, CA) according to the manufacturer's instructions. Levels of receptor-activator of nuclear factor kappa B (RANKL), osteoprotegerin (OPG) and IL-23 were measured in paw homogenate supernatants using kits from R&#x00026;D Systems (Minneapolis, MN) according to the manufacturer's instructions. Levels of CTX-I and TRAP were measured in serum and paw homogenate supernatants using ELISA kits from Immunodiagnostic Systems (Boldon, UK) according to the manufacturer's instructions. Levels of MMP3, IL-6 and G-CSF were measured in serum using kits from R&#x00026;D Systems (Minneapolis, MN) according to the manufacturer's instructions. Antibodies to mutated citrullinated vimentin (anti-MCV) were measured using kits from Orgentec Diagnostika GmbH (Mainz, Germany) with the modification that the detection antibody supplied in the kit was substituted with goat anti-mouse IgG-HRP (Invitrogen, Carlsbad, CA) diluted 1:3000 and the substrate solution supplied was substituted with substrate reagents from R&#x00026;D Systems (Minneapolis, MN).</p></sec><sec id="s4k"><title>mRNA deep sequencing</title><p>Arthritic hind paws were removed at the hairline and homogenised in Qiagen RLT buffer (Qiagen, Germantown, MD) with 1% 2-betamercaptoethanol (Sigma-Aldrich, St Louis, MO) and stored at &#x02212;80&#x000b0;C. The Ambion Magmax prep protocol was used to extract total RNA. RNA quantity was assessed using the Nanodrop and RNA quality was assessed using the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNAseq libraries were prepared using the Illumina TruSeq Sample Prep Kit (Illumina, Inc., San Diego, CA). 120&#x02005;ng of total RNA was used for input. Barcode adapters were added to samples in such a way as to allow pooling of samples in flow cell lanes in a randomized pattern relative to sample annotation and source. Samples were sequenced using an Illumina HiSeq 2000 (Illumina, Inc., San Diego, CA) at a multiplexing level sufficient to generation 10-million to 25-million reads per sample. Following generation of sequence, reads were aligned to the mouse genome version NCBI m37 using TopHat (<uri xlink:href="http://tophat.cbcb.umd.edu/">http://tophat.cbcb.umd.edu/</uri>). Quality control of sequencing data was accomplished by using the ShortRead package in R (<uri xlink:href="http://www.r-project.org/">http://www.r-project.org/</uri>). Aligned reads were mapped to Ensembl transcript models and converted to reads per kilobase of transcript per million mapped reads (RPKM) values using Cufflinks (<uri xlink:href="http://cufflinks.cbcb.umd.edu/">http://cufflinks.cbcb.umd.edu/</uri>).</p></sec><sec id="s4l"><title>Bacterial 16s rDNA sequencing</title><p>Bacterial DNA from fecal samples from the distal colon was extracted using the NucleoSpin soil kit (Macherey-Nagel, D&#x000fc;ren, Germany) following the manufacturer's protocol. Yield and integrity of the DNA were assessed by Nanodrop and agarose gel electrophoresis, respectively. 16S rDNA amplification and library generation were performed as previously described (<xref rid="DMM022905C19" ref-type="bibr">Holm et al., 2015</xref>). PCR products were purified using Agencourt AMPure XP beads (Beckman Coulter, Brea, CA) and normalized to 16-21&#x02005;ng/&#x003bc;l per sample. Subsequently, samples were pooled (5&#x02005;&#x003bc;l of each sample) and quantified using a Qubit dsDNA HS Assay Kit and a Qubit 2.0 Fluorometer (Life Technologies, Carlsbad, CA). 14&#x02005;pM library and 0.7&#x02005;pM PhiX Control v3 (Illumina, San Diego, CA) were sequenced using an Illumina MiSeq V2 PE500 cartridge (500 cycles) on an Illumina MiSeq. Sequences were analysed using QIIME v1.7.0 with default settings including quality-based sequence trimming, removal of primers, assembly of paired-end sequences and chimera checking (<xref rid="DMM022905C5" ref-type="bibr">Caporaso et al., 2010</xref>). <italic>De novo</italic> operational taxonomic unit (OTU)-picking was performed by UCLUST (<xref rid="DMM022905C8" ref-type="bibr">Edgar, 2010</xref>) utilizing 97% sequence similarity. OTUs were assigned against the Greengenes database v11_2 (<xref rid="DMM022905C7" ref-type="bibr">DeSantis et al., 2006</xref>) using the RDP-classifier (<xref rid="DMM022905C60" ref-type="bibr">Wang et al., 2007</xref>) with an 80% confidence threshold. Analyses were performed in R v3.2.0 using the metagenomeSeq (<xref rid="DMM022905C47" ref-type="bibr">Paulson et al., 2013</xref>), PhyloSeq (<xref rid="DMM022905C40" ref-type="bibr">McMurdie and Holmes, 2013</xref>) and Vegan (<xref rid="DMM022905C45" ref-type="bibr">Oksanen et al., 2011</xref>) packages. Data was filtered for low-abundant OTUs by removing OTUs present in fewer than three of the 42 samples and with a relative abundance across all samples &#x02264;0.5%. Analyses on filtered data were performed with an average of 20,731&#x000b1;7655 (s.d.) sequences per sample compared to an initial 24,974&#x000b1;9382 (s.d.) sequences before filtering. Alpha diversity (Shannon index) was calculated on unfiltered data. Read counts were normalized using metagenomeSeq (<xref rid="DMM022905C47" ref-type="bibr">Paulson et al., 2013</xref>), which utilizes a cumulative-sum scaling where raw counts are divided by the cumulative sum of counts up to a particular quantile. Principal coordinate analysis (PCoA) using Bray-Curtis dissimilarity indices, analysis of differential abundance of taxa and beta diversity analysis using Whittaker's species turnover were performed on filtered and normalized data.</p></sec><sec id="s4m"><title>Statistics</title><p>Statistical analyses were conducted using GraphPad Prism software version 6.04. Non-parametric data or non-normal parametric data were analysed using the Mann&#x02013;Whitney <italic>U</italic>-test, and parametric data were analysed using a two-sided unpaired Student's <italic>t</italic>-test or one-way ANOVA. For statistical analysis of the histology score data, a two-sided unpaired Student's <italic>t</italic>-test with Welch's correction was used. For bacterial 16S rDNA, statistical analyses were conducted using R differences in abundance of phyla, alpha diversity measures and beta diversity between and within the FoxP3-DTR<sup>&#x02212;</sup> and FoxP3-DTR<sup>+</sup> groups over the course of the study using the Wilcoxon Rank-Sum and Wilcoxon Signed-Rank test, respectively, with Benjamini&#x02013;Hochberg <italic>P</italic>-value adjustment. Adonis test of significance was performed using the calculated Bray&#x02013;Curtis distance matrix, to test for overall differences between the FoxP3-DTR<sup>&#x02212;</sup> and FoxP3-DTR<sup>+</sup> groups and within each group over the course of the study. Correlation analyses between taxonomic abundances, alpha diversity, serum markers, and paw and ankle size were performed in R using Spearman's rank correlation test with Benjamini&#x02013;Hochberg <italic>P</italic>-value adjustment. Differences between groups and correlation coefficients were considered significant when <italic>P</italic>&#x02264;0.05 and levels of significance were assigned as *<italic>P</italic>&#x02264;0.05, **<italic>P</italic>&#x02264;0.01 and ***<italic>P</italic>&#x02264;0.001. In <xref ref-type="fig" rid="DMM022905F6">Figs&#x000a0;6</xref> and <xref ref-type="fig" rid="DMM022905F7">7</xref>E <italic>P</italic>-values were corrected for mass significance using the False Discovery Rate method. The raw and corrected <italic>P</italic>-values are shown in <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">Table&#x000a0;S1</uri>.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>The authors sincerely thank Kirstine Smedenfors, Mie Berndorff, Julie Jensen, Sara Louise Riisberg, Malik Nygaard Nielsen and Lise-Lotte Kruse for excellent technical assistance, and the staff of Laboratory Animal Science, Novo Nordisk A/S, Maaloev for assisting with blood sampling.</p></ack><fn-group><title>Footnotes</title><fn fn-type="conflict"><p><bold>Competing interests</bold></p><p>The authors declare no competing or financial interests.</p></fn><fn><p><bold>Author contributions</bold></p><p>S.M.A. designed, performed and analysed the animal studies, immunoassays, flow cytometry, histopathology and immunohistochemistry, and drafted the manuscript. A.N. conceived the study, participated in its design and coordination, and provided intellectual support. U.H. and A.H. assisted in designing animal studies and provided intellectual support. E.B. and N.B.D.-S. performed the analysis of fecal microbiota composition, analysed the results and helped draft the manuscript. K.S., B.F. and K.Kruse performed and analysed the mRNA deep sequencing. K.Kristiansen, S.S. and C.H. helped draft the manuscript and provided intellectual support. All authors read and approved the final manuscript.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding</bold></p><p>This study was funded in full by Novo Nordisk A/S and the LIFEPHARM Novo Nordisk &#x00026; LIFE In Vivo Pharmacology Centre at the University of Copenhagen.</p></fn><fn fn-type="supplementary-material"><p><bold>Supplementary information</bold></p><p>Supplementary information available online at <uri xlink:href="http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1">http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.022905/-/DC1</uri></p></fn></fn-group><ref-list><title>References</title><ref id="DMM022905C1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdollahi-Roodsaz</surname><given-names>S.</given-names></name>, <name><surname>Joosten</surname><given-names>L. A. B.</given-names></name>, <name><surname>Koenders</surname><given-names>M. I.</given-names></name>, <name><surname>Devesa</surname><given-names>I.</given-names></name>, <name><surname>Roelofs</surname><given-names>M. F.</given-names></name>, <name><surname>Radstake</surname><given-names>T. R. D. J.</given-names></name>, <name><surname>Heuvelmans-Jacobs</surname><given-names>M.</given-names></name>, <name><surname>Akira</surname><given-names>S.</given-names></name>, <name><surname>Nicklin</surname><given-names>M. J. H.</given-names></name>, <name><surname>Ribeiro-Dias</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis</article-title>. <source><italic>J. Clin. Invest.</italic></source>
<volume>118</volume>, <fpage>205</fpage>-<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1172/JCI32639</pub-id><pub-id pub-id-type="pmid">18060042</pub-id></mixed-citation></ref><ref id="DMM022905C2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asquith</surname><given-names>D. L.</given-names></name>, <name><surname>Miller</surname><given-names>A. M.</given-names></name>, <name><surname>McInnes</surname><given-names>I. B.</given-names></name> and <name><surname>Liew</surname><given-names>F. Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Animal models of rheumatoid arthritis</article-title>. <source><italic>Eur. J. Immunol.</italic></source>
<volume>39</volume>, <fpage>2040</fpage>-<lpage>2044</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200939578</pub-id><pub-id pub-id-type="pmid">19672892</pub-id></mixed-citation></ref><ref id="DMM022905C3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>S. M.</given-names></name>, <name><surname>Usher</surname><given-names>P. A.</given-names></name>, <name><surname>Kvist</surname><given-names>P. H.</given-names></name>, <name><surname>Markholst</surname><given-names>H.</given-names></name>, <name><surname>Haase</surname><given-names>C.</given-names></name> and <name><surname>Nansen</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Establishment and characterization of a sustained delayed-type hypersensitivity model with arthritic manifestations in C57BL/6J mice</article-title>. <source><italic>Arthritis Res. Ther.</italic></source>
<volume>14</volume>, <fpage>R134</fpage>
<pub-id pub-id-type="doi">10.1186/ar3867</pub-id><pub-id pub-id-type="pmid">22676339</pub-id></mixed-citation></ref><ref id="DMM022905C4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkinson</surname><given-names>S. M.</given-names></name>, <name><surname>Nansen</surname><given-names>A.</given-names></name>, <name><surname>Usher</surname><given-names>P. A.</given-names></name>, <name><surname>Sondergaard</surname><given-names>B. C.</given-names></name>, <name><surname>Mackay</surname><given-names>C. R.</given-names></name>, <name><surname>Friedrichsen</surname><given-names>B.</given-names></name>, <name><surname>Chang</surname><given-names>C. C.</given-names></name>, <name><surname>Tang</surname><given-names>R.</given-names></name>, <name><surname>Skov</surname><given-names>S.</given-names></name>, <name><surname>Haase</surname><given-names>C.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model</article-title>. <source><italic>Autoimmunity</italic></source>
<volume>48</volume>, <fpage>460</fpage>-<lpage>470</lpage>. <pub-id pub-id-type="doi">10.3109/08916934.2015.1031888</pub-id><pub-id pub-id-type="pmid">25915570</pub-id></mixed-citation></ref><ref id="DMM022905C5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname><given-names>J. G.</given-names></name>, <name><surname>Kuczynski</surname><given-names>J.</given-names></name>, <name><surname>Stombaugh</surname><given-names>J.</given-names></name>, <name><surname>Bittinger</surname><given-names>K.</given-names></name>, <name><surname>Bushman</surname><given-names>F. D.</given-names></name>, <name><surname>Costello</surname><given-names>E. K.</given-names></name>, <name><surname>Fierer</surname><given-names>N.</given-names></name>, <name><surname>Pe&#x000f1;a</surname><given-names>A. G.</given-names></name>, <name><surname>Goodrich</surname><given-names>J. K.</given-names></name>, <name><surname>Gordon</surname><given-names>J. I.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>QIIME allows analysis of high-throughput community sequencing data</article-title>. <source><italic>Nat. Methods</italic></source>
<volume>7</volume>, <fpage>335</fpage>-<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.f.303</pub-id><pub-id pub-id-type="pmid">20383131</pub-id></mixed-citation></ref><ref id="DMM022905C6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denninger</surname><given-names>K. C. M.</given-names></name>, <name><surname>Litman</surname><given-names>T.</given-names></name>, <name><surname>Marstrand</surname><given-names>T.</given-names></name>, <name><surname>Moller</surname><given-names>K.</given-names></name>, <name><surname>Svensson</surname><given-names>L.</given-names></name>, <name><surname>Labuda</surname><given-names>T.</given-names></name> and <name><surname>Andersson</surname><given-names>&#x000c5;.</given-names></name></person-group> (<year>2015</year>). <article-title>Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis</article-title>. <source><italic>Arthritis Res. Ther.</italic></source>
<volume>17</volume>, <fpage>43</fpage>
<pub-id pub-id-type="doi">10.1186/s13075-015-0531-7</pub-id><pub-id pub-id-type="pmid">25889670</pub-id></mixed-citation></ref><ref id="DMM022905C7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSantis</surname><given-names>T. Z.</given-names></name>, <name><surname>Hugenholtz</surname><given-names>P.</given-names></name>, <name><surname>Larsen</surname><given-names>N.</given-names></name>, <name><surname>Rojas</surname><given-names>M.</given-names></name>, <name><surname>Brodie</surname><given-names>E. L.</given-names></name>, <name><surname>Keller</surname><given-names>K.</given-names></name>, <name><surname>Huber</surname><given-names>T.</given-names></name>, <name><surname>Dalevi</surname><given-names>D.</given-names></name>, <name><surname>Hu</surname><given-names>P.</given-names></name> and <name><surname>Andersen</surname><given-names>G. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB</article-title>. <source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>72</volume>, <fpage>5069</fpage>-<lpage>5072</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.03006-05</pub-id><pub-id pub-id-type="pmid">16820507</pub-id></mixed-citation></ref><ref id="DMM022905C8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>R. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Search and clustering orders of magnitude faster than BLAST</article-title>. <source><italic>Bioinformatics</italic></source>
<volume>26</volume>, <fpage>2460</fpage>-<lpage>2461</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq461</pub-id><pub-id pub-id-type="pmid">20709691</pub-id></mixed-citation></ref><ref id="DMM022905C9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feuerer</surname><given-names>M.</given-names></name>, <name><surname>Shen</surname><given-names>Y.</given-names></name>, <name><surname>Littman</surname><given-names>D. R.</given-names></name>, <name><surname>Benoist</surname><given-names>C.</given-names></name> and <name><surname>Mathis</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets</article-title>. <source><italic>Immunity</italic></source>
<volume>31</volume>, <fpage>654</fpage>-<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.023</pub-id><pub-id pub-id-type="pmid">19818653</pub-id></mixed-citation></ref><ref id="DMM022905C10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fielding</surname><given-names>C. A.</given-names></name>, <name><surname>McLoughlin</surname><given-names>R. M.</given-names></name>, <name><surname>McLeod</surname><given-names>L.</given-names></name>, <name><surname>Colmont</surname><given-names>C. S.</given-names></name>, <name><surname>Najdovska</surname><given-names>M.</given-names></name>, <name><surname>Grail</surname><given-names>D.</given-names></name>, <name><surname>Ernst</surname><given-names>M.</given-names></name>, <name><surname>Jones</surname><given-names>S. A.</given-names></name>, <name><surname>Topley</surname><given-names>N.</given-names></name> and <name><surname>Jenkins</surname><given-names>B. J.</given-names></name></person-group> (<year>2008</year>). <article-title>IL-6 regulates neutrophil trafficking during acute inflammation via STAT3</article-title>. <source><italic>J. Immunol.</italic></source>
<volume>181</volume>, <fpage>2189</fpage>-<lpage>2195</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.181.3.2189</pub-id><pub-id pub-id-type="pmid">18641358</pub-id></mixed-citation></ref><ref id="DMM022905C11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillatreau</surname><given-names>S.</given-names></name>, <name><surname>Sweenie</surname><given-names>C. H.</given-names></name>, <name><surname>McGeachy</surname><given-names>M. J.</given-names></name>, <name><surname>Gray</surname><given-names>D.</given-names></name> and <name><surname>Anderton</surname><given-names>S. M.</given-names></name></person-group> (<year>2002</year>). <article-title>B cells regulate autoimmunity by provision of IL-10</article-title>. <source><italic>Nat. Immunol.</italic></source>
<volume>3</volume>, <fpage>944</fpage>-<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1038/ni833</pub-id><pub-id pub-id-type="pmid">12244307</pub-id></mixed-citation></ref><ref id="DMM022905C12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>O.</given-names></name>, <name><surname>Petrow</surname><given-names>P. K.</given-names></name>, <name><surname>Gajda</surname><given-names>M.</given-names></name>, <name><surname>Siegmund</surname><given-names>K.</given-names></name>, <name><surname>Huehn</surname><given-names>J.</given-names></name>, <name><surname>Scheffold</surname><given-names>A.</given-names></name>, <name><surname>Hamann</surname><given-names>A.</given-names></name>, <name><surname>Radbruch</surname><given-names>A.</given-names></name> and <name><surname>Br&#x000e4;uer</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells</article-title>. <source><italic>Arthritis Res. Ther.</italic></source>
<volume>7</volume>, <fpage>R291</fpage>-<lpage>R301</lpage>. <pub-id pub-id-type="doi">10.1186/ar1484</pub-id><pub-id pub-id-type="pmid">15743476</pub-id></mixed-citation></ref><ref id="DMM022905C13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>O.</given-names></name>, <name><surname>Reichel</surname><given-names>A.</given-names></name>, <name><surname>Bonhagen</surname><given-names>K.</given-names></name>, <name><surname>Morawietz</surname><given-names>L.</given-names></name>, <name><surname>Rauchhaus</surname><given-names>U.</given-names></name> and <name><surname>Kamradt</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis</article-title>. <source><italic>Ann. Rheum. Dis</italic></source>
<volume>69</volume>, <fpage>1511</fpage>-<lpage>1518</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2009.123422</pub-id><pub-id pub-id-type="pmid">20498199</pub-id></mixed-citation></ref><ref id="DMM022905C14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>L. C.</given-names></name>, <name><surname>Chen</surname><given-names>H.</given-names></name>, <name><surname>Lu</surname><given-names>X.</given-names></name> and <name><surname>Nanes</surname><given-names>M. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Chronic low dose tumor necrosis factor-&#x003b1; (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts</article-title>. <source><italic>Bone</italic></source>
<volume>56</volume>, <fpage>174</fpage>-<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2013.06.002</pub-id><pub-id pub-id-type="pmid">23756233</pub-id></mixed-citation></ref><ref id="DMM022905C15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gizinski</surname><given-names>A. M.</given-names></name> and <name><surname>Fox</surname><given-names>D. A.</given-names></name></person-group> (<year>2014</year>). <article-title>T cell subsets and their role in the pathogenesis of rheumatic disease</article-title>. <source><italic>Curr. Opin. Rheumatol.</italic></source>
<volume>26</volume>, <fpage>204</fpage>-<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1097/BOR.0000000000000036</pub-id><pub-id pub-id-type="pmid">24445478</pub-id></mixed-citation></ref><ref id="DMM022905C16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudmann</surname><given-names>N. S.</given-names></name>, <name><surname>Hansen</surname><given-names>N. U. B.</given-names></name>, <name><surname>Jensen</surname><given-names>A. C. B.</given-names></name>, <name><surname>Karsdal</surname><given-names>M. A.</given-names></name> and <name><surname>Siebuhr</surname><given-names>A. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options</article-title>. <source><italic>Autoimmunity</italic></source>
<volume>48</volume>, <fpage>73</fpage>-<lpage>79</lpage>. <pub-id pub-id-type="doi">10.3109/08916934.2014.962024</pub-id><pub-id pub-id-type="pmid">25520183</pub-id></mixed-citation></ref><ref id="DMM022905C17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>J. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Colony-stimulating factors in inflammation and autoimmunity</article-title>. <source><italic>Nat. Rev. Immunol.</italic></source>
<volume>8</volume>, <fpage>533</fpage>-<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1038/nri2356</pub-id><pub-id pub-id-type="pmid">18551128</pub-id></mixed-citation></ref><ref id="DMM022905C18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>K. R.</given-names></name>, <name><surname>Pettit</surname><given-names>A. R.</given-names></name>, <name><surname>Duan</surname><given-names>R.</given-names></name>, <name><surname>Tseng</surname><given-names>H.-W.</given-names></name>, <name><surname>Glant</surname><given-names>T. T.</given-names></name>, <name><surname>Brown</surname><given-names>M. A.</given-names></name> and <name><surname>Thomas</surname><given-names>G. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors</article-title>. <source><italic>Arthritis Res. Ther.</italic></source>
<volume>14</volume>, <fpage>R253</fpage>
<pub-id pub-id-type="doi">10.1186/ar4096</pub-id><pub-id pub-id-type="pmid">23171658</pub-id></mixed-citation></ref><ref id="DMM022905C19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname><given-names>J. B.</given-names></name>, <name><surname>Sorobetea</surname><given-names>D.</given-names></name>, <name><surname>Kiilerich</surname><given-names>P.</given-names></name>, <name><surname>Ramayo-Caldas</surname><given-names>Y.</given-names></name>, <name><surname>Estell&#x000e9;</surname><given-names>J.</given-names></name>, <name><surname>Ma</surname><given-names>T.</given-names></name>, <name><surname>Madsen</surname><given-names>L.</given-names></name>, <name><surname>Kristiansen</surname><given-names>K.</given-names></name> and <name><surname>Svensson-Frej</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Chronic <italic>Trichuris muris</italic> infection decreases diversity of the intestinal microbiota and concomitantly increases the abundance of lactobacilli</article-title>. <source><italic>PLoS ONE</italic></source>
<volume>10</volume>, <fpage>e0125495</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0125495</pub-id><pub-id pub-id-type="pmid">25942314</pub-id></mixed-citation></ref><ref id="DMM022905C20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutamekalin</surname><given-names>P.</given-names></name>, <name><surname>Saito</surname><given-names>T.</given-names></name>, <name><surname>Yamaki</surname><given-names>K.</given-names></name>, <name><surname>Mizutani</surname><given-names>N.</given-names></name>, <name><surname>Brand</surname><given-names>D. D.</given-names></name>, <name><surname>Waritani</surname><given-names>T.</given-names></name>, <name><surname>Terato</surname><given-names>K.</given-names></name> and <name><surname>Yoshino</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies</article-title>. <source><italic>J. Immunol. Methods</italic></source>
<volume>343</volume>, <fpage>49</fpage>-<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.jim.2009.01.009</pub-id><pub-id pub-id-type="pmid">19330909</pub-id></mixed-citation></ref><ref id="DMM022905C21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irmler</surname><given-names>I. M.</given-names></name>, <name><surname>Gajda</surname><given-names>M.</given-names></name> and <name><surname>Kamradt</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Amelioration of experimental arthritis by stroke-induced immunosuppression is independent of Treg cell function</article-title>. <source><italic>Ann. Rheum. Dis.</italic></source>
<volume>73</volume>, <fpage>2183</fpage>-<lpage>2191</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2013-204148</pub-id><pub-id pub-id-type="pmid">24326006</pub-id></mixed-citation></ref><ref id="DMM022905C22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jago</surname><given-names>C. B.</given-names></name>, <name><surname>Yates</surname><given-names>J.</given-names></name>, <name><surname>Olsen Saraiva C&#x000e2;mara</surname><given-names>N.</given-names></name>, <name><surname>Lechler</surname><given-names>R. I.</given-names></name> and <name><surname>Lombardi</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Differential expression of CTLA-4 among T cell subsets</article-title>. <source><italic>Clin. Exp. Immunol.</italic></source>
<volume>136</volume>, <fpage>463</fpage>-<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2004.02478.x</pub-id><pub-id pub-id-type="pmid">15147348</pub-id></mixed-citation></ref><ref id="DMM022905C23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jilani</surname><given-names>A. A.</given-names></name> and <name><surname>Mackworth-Young</surname><given-names>C. G.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis</article-title>. <source><italic>Int. J. Rheumatol.</italic></source>
<volume>2015</volume>, <fpage>728610</fpage>
<pub-id pub-id-type="doi">10.1155/2015/728610</pub-id><pub-id pub-id-type="pmid">25821469</pub-id></mixed-citation></ref><ref id="DMM022905C24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelchtermans</surname><given-names>H.</given-names></name>, <name><surname>De Klerck</surname><given-names>B.</given-names></name>, <name><surname>Mitera</surname><given-names>T.</given-names></name>, <name><surname>Van Balen</surname><given-names>M.</given-names></name>, <name><surname>Bullens</surname><given-names>D.</given-names></name>, <name><surname>Billiau</surname><given-names>A.</given-names></name>, <name><surname>Leclercq</surname><given-names>G.</given-names></name> and <name><surname>Matthys</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma</article-title>. <source><italic>Arthritis Res. Ther.</italic></source>
<volume>7</volume>, <fpage>R402</fpage>-<lpage>R415</lpage>. <pub-id pub-id-type="doi">10.1186/ar1500</pub-id><pub-id pub-id-type="pmid">15743488</pub-id></mixed-citation></ref><ref id="DMM022905C25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelchtermans</surname><given-names>H.</given-names></name>, <name><surname>Geboes</surname><given-names>L.</given-names></name>, <name><surname>Mitera</surname><given-names>T.</given-names></name>, <name><surname>Huskens</surname><given-names>D.</given-names></name>, <name><surname>Leclercq</surname><given-names>G.</given-names></name> and <name><surname>Matthys</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis</article-title>. <source><italic>Ann. Rheum. Dis.</italic></source>
<volume>68</volume>, <fpage>744</fpage>-<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2007.086066</pub-id><pub-id pub-id-type="pmid">18480308</pub-id></mixed-citation></ref><ref id="DMM022905C26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>K. K.</given-names></name>, <name><surname>Thomsen</surname><given-names>J. S.</given-names></name>, <name><surname>Stengaard-Pedersen</surname><given-names>K.</given-names></name>, <name><surname>Dagn&#x000e6;s-Hansen</surname><given-names>F.</given-names></name>, <name><surname>Nyengaard</surname><given-names>J. R.</given-names></name> and <name><surname>Hauge</surname><given-names>E.-M.</given-names></name></person-group> (<year>2012</year>). <article-title>Bone formation and resorption are both increased in experimental autoimmune arthritis</article-title>. <source><italic>PLoS ONE</italic></source>
<volume>7</volume>, <fpage>e53034</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0053034</pub-id><pub-id pub-id-type="pmid">23300855</pub-id></mixed-citation></ref><ref id="DMM022905C27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolls</surname><given-names>J. K.</given-names></name> and <name><surname>Lind&#x000e9;n</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Interleukin-17 family members and inflammation</article-title>. <source><italic>Immunity</italic></source>
<volume>21</volume>, <fpage>467</fpage>-<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2004.08.018</pub-id><pub-id pub-id-type="pmid">15485625</pub-id></mixed-citation></ref><ref id="DMM022905C28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahl</surname><given-names>K.</given-names></name> and <name><surname>Sparwasser</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>In vivo depletion of FoxP3+ Tregs using the DEREG mouse model</article-title>. <source><italic>Methods Mol. Biol.</italic></source>
<volume>707</volume>, <fpage>157</fpage>-<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61737-979-6_10</pub-id><pub-id pub-id-type="pmid">21287334</pub-id></mixed-citation></ref><ref id="DMM022905C29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahl</surname><given-names>K.</given-names></name>, <name><surname>Loddenkemper</surname><given-names>C.</given-names></name>, <name><surname>Drouin</surname><given-names>C.</given-names></name>, <name><surname>Freyer</surname><given-names>J.</given-names></name>, <name><surname>Arnason</surname><given-names>J.</given-names></name>, <name><surname>Eberl</surname><given-names>G.</given-names></name>, <name><surname>Hamann</surname><given-names>A.</given-names></name>, <name><surname>Wagner</surname><given-names>H.</given-names></name>, <name><surname>Huehn</surname><given-names>J.</given-names></name> and <name><surname>Sparwasser</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease</article-title>. <source><italic>J. Exp. Med.</italic></source>
<volume>204</volume>, <fpage>57</fpage>-<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20061852</pub-id><pub-id pub-id-type="pmid">17200412</pub-id></mixed-citation></ref><ref id="DMM022905C30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lally</surname><given-names>F.</given-names></name>, <name><surname>Smith</surname><given-names>E.</given-names></name>, <name><surname>Filer</surname><given-names>A.</given-names></name>, <name><surname>Stone</surname><given-names>M. A.</given-names></name>, <name><surname>Shaw</surname><given-names>J. S.</given-names></name>, <name><surname>Nash</surname><given-names>G. B.</given-names></name>, <name><surname>Buckley</surname><given-names>C. D.</given-names></name> and <name><surname>Ed Rainger</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium</article-title>. <source><italic>Arthritis Rheum.</italic></source>
<volume>52</volume>, <fpage>3460</fpage>-<lpage>3469</lpage>. <pub-id pub-id-type="doi">10.1002/art.21394</pub-id><pub-id pub-id-type="pmid">16255036</pub-id></mixed-citation></ref><ref id="DMM022905C31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampropoulou</surname><given-names>V.</given-names></name>, <name><surname>Hoehlig</surname><given-names>K.</given-names></name>, <name><surname>Roch</surname><given-names>T.</given-names></name>, <name><surname>Neves</surname><given-names>P.</given-names></name>, <name><surname>G&#x000f3;mez</surname><given-names>E. C.</given-names></name>, <name><surname>Sweenie</surname><given-names>C. H.</given-names></name>, <name><surname>Hao</surname><given-names>Y.</given-names></name>, <name><surname>Freitas</surname><given-names>A. A.</given-names></name>, <name><surname>Steinhoff</surname><given-names>U.</given-names></name>, <name><surname>Anderton</surname><given-names>S. M.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>TLR-activated B cells suppress T cell-mediated autoimmunity</article-title>. <source><italic>J. Immunol.</italic></source>
<volume>180</volume>, <fpage>4763</fpage>-<lpage>4773</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.180.7.4763</pub-id><pub-id pub-id-type="pmid">18354200</pub-id></mixed-citation></ref><ref id="DMM022905C32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name>, <name><surname>Zou</surname><given-names>Q.</given-names></name>, <name><surname>Zeng</surname><given-names>B.</given-names></name>, <name><surname>Fang</surname><given-names>Y.</given-names></name> and <name><surname>Wei</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Analysis of fecal lactobacillus community structure in patients with early rheumatoid arthritis</article-title>. <source><italic>Curr. Microbiol.</italic></source>
<volume>67</volume>, <fpage>170</fpage>-<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1007/s00284-013-0338-1</pub-id><pub-id pub-id-type="pmid">23483307</pub-id></mixed-citation></ref><ref id="DMM022905C33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohr</surname><given-names>J.</given-names></name>, <name><surname>Knoechel</surname><given-names>B.</given-names></name>, <name><surname>Wang</surname><given-names>J. J.</given-names></name>, <name><surname>Villarino</surname><given-names>A. V.</given-names></name> and <name><surname>Abbas</surname><given-names>A. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease</article-title>. <source><italic>J. Exp. Med.</italic></source>
<volume>203</volume>, <fpage>2785</fpage>-<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20061341</pub-id><pub-id pub-id-type="pmid">17130300</pub-id></mixed-citation></ref><ref id="DMM022905C34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubberts</surname><given-names>E.</given-names></name>, <name><surname>Joosten</surname><given-names>L. A. B.</given-names></name>, <name><surname>Oppers</surname><given-names>B.</given-names></name>, <name><surname>van den Bersselaar</surname><given-names>L.</given-names></name>, <name><surname>Coenen-de Roo</surname><given-names>C. J. J.</given-names></name>, <name><surname>Kolls</surname><given-names>J. K.</given-names></name>, <name><surname>Schwarzenberger</surname><given-names>P.</given-names></name>, <name><surname>van de Loo</surname><given-names>F. A. J.</given-names></name> and <name><surname>van den Berg</surname><given-names>W. B.</given-names></name></person-group> (<year>2001</year>). <article-title>IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis</article-title>. <source><italic>J. Immunol.</italic></source>
<volume>167</volume>, <fpage>1004</fpage>-<lpage>1013</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.167.2.1004</pub-id><pub-id pub-id-type="pmid">11441109</pub-id></mixed-citation></ref><ref id="DMM022905C35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubberts</surname><given-names>E.</given-names></name>, <name><surname>Koenders</surname><given-names>M. I.</given-names></name>, <name><surname>Oppers-Walgreen</surname><given-names>B.</given-names></name>, <name><surname>van den Bersselaar</surname><given-names>L.</given-names></name>, <name><surname>Coenen-de Roo</surname><given-names>C. J. J.</given-names></name>, <name><surname>Joosten</surname><given-names>L. A. B.</given-names></name> and <name><surname>van den Berg</surname><given-names>W. B.</given-names></name></person-group> (<year>2004</year>). <article-title>Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion</article-title>. <source><italic>Arthritis Rheum.</italic></source>
<volume>50</volume>, <fpage>650</fpage>-<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1002/art.20001</pub-id><pub-id pub-id-type="pmid">14872510</pub-id></mixed-citation></ref><ref id="DMM022905C36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubberts</surname><given-names>E.</given-names></name>, <name><surname>Koenders</surname><given-names>M. I.</given-names></name> and <name><surname>van den Berg</surname><given-names>W.</given-names></name></person-group> (<year>2005</year>). <article-title>The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models</article-title>. <source><italic>Arthritis Res. Ther.</italic></source>
<volume>7</volume>, <fpage>29</fpage>-<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1186/ar1478</pub-id><pub-id pub-id-type="pmid">15642151</pub-id></mixed-citation></ref><ref id="DMM022905C37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maksymowych</surname><given-names>W. P.</given-names></name>, <name><surname>Morency</surname><given-names>N.</given-names></name>, <name><surname>Conner-Spady</surname><given-names>B.</given-names></name> and <name><surname>Lambert</surname><given-names>R. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification</article-title>. <source><italic>Ann. Rheum. Dis.</italic></source>
<volume>72</volume>, <fpage>23</fpage>-<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2011-200859</pub-id><pub-id pub-id-type="pmid">22562977</pub-id></mixed-citation></ref><ref id="DMM022905C38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauri</surname><given-names>C.</given-names></name>, <name><surname>Gray</surname><given-names>D.</given-names></name>, <name><surname>Mushtaq</surname><given-names>N.</given-names></name> and <name><surname>Londei</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Prevention of arthritis by Interleukin 10&#x02013;producing B Cells</article-title>. <source><italic>J. Exp. Med.</italic></source>
<volume>197</volume>, <fpage>489</fpage>-<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20021293</pub-id><pub-id pub-id-type="pmid">12591906</pub-id></mixed-citation></ref><ref id="DMM022905C39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maynard</surname><given-names>C. L.</given-names></name>, <name><surname>Elson</surname><given-names>C. O.</given-names></name>, <name><surname>Hatton</surname><given-names>R. D.</given-names></name> and <name><surname>Weaver</surname><given-names>C. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Reciprocal interactions of the intestinal microbiota and immune system</article-title>. <source><italic>Nature</italic></source>
<volume>489</volume>, <fpage>231</fpage>-<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1038/nature11551</pub-id><pub-id pub-id-type="pmid">22972296</pub-id></mixed-citation></ref><ref id="DMM022905C40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurdie</surname><given-names>P. J.</given-names></name> and <name><surname>Holmes</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data</article-title>. <source><italic>PLoS ONE</italic></source>
<volume>8</volume>, <fpage>e61217</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0061217</pub-id><pub-id pub-id-type="pmid">23630581</pub-id></mixed-citation></ref><ref id="DMM022905C41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyara</surname><given-names>M.</given-names></name>, <name><surname>Ito</surname><given-names>Y.</given-names></name> and <name><surname>Sakaguchi</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>TREG-cell therapies for autoimmune rheumatic diseases</article-title>. <source><italic>Nat. Rev. Rheumatol.</italic></source>
<volume>10</volume>, <fpage>543</fpage>-<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2014.105</pub-id><pub-id pub-id-type="pmid">24980140</pub-id></mixed-citation></ref><ref id="DMM022905C42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizoguchi</surname><given-names>A.</given-names></name>, <name><surname>Mizoguchi</surname><given-names>E.</given-names></name>, <name><surname>Smith</surname><given-names>R. N.</given-names></name>, <name><surname>Preffer</surname><given-names>F. I.</given-names></name> and <name><surname>Bhan</surname><given-names>A. K.</given-names></name></person-group> (<year>1997</year>). <article-title>Suppressive role of B cells in chronic colitis of T cell receptor &#x003b1; mutant mice</article-title>. <source><italic>J. Exp. Med.</italic></source>
<volume>186</volume>, <fpage>1749</fpage>-<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1084/jem.186.10.1749</pub-id><pub-id pub-id-type="pmid">9362534</pub-id></mixed-citation></ref><ref id="DMM022905C43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>M. E.</given-names></name>, <name><surname>Sutmuller</surname><given-names>R. P. M.</given-names></name>, <name><surname>Witteveen</surname><given-names>H. J.</given-names></name>, <name><surname>van Duivenvoorde</surname><given-names>L. M.</given-names></name>, <name><surname>Zanelli</surname><given-names>E.</given-names></name>, <name><surname>Melief</surname><given-names>C. J. M.</given-names></name>, <name><surname>Snijders</surname><given-names>A.</given-names></name>, <name><surname>Offringa</surname><given-names>R.</given-names></name>, <name><surname>de Vries</surname><given-names>R. R. P.</given-names></name> and <name><surname>Toes</surname><given-names>R. E. M.</given-names></name></person-group> (<year>2003</year>). <article-title>CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis</article-title>. <source><italic>Arthritis Rheum.</italic></source>
<volume>48</volume>, <fpage>1452</fpage>-<lpage>1460</lpage>. <pub-id pub-id-type="doi">10.1002/art.11063</pub-id><pub-id pub-id-type="pmid">12746920</pub-id></mixed-citation></ref><ref id="DMM022905C44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noack</surname><given-names>M.</given-names></name> and <name><surname>Miossec</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Th17 and regulatory T cell balance in autoimmune and inflammatory diseases</article-title>. <source><italic>Autoimmun. Rev.</italic></source>
<volume>13</volume>, <fpage>668</fpage>-<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2013.12.004</pub-id><pub-id pub-id-type="pmid">24418308</pub-id></mixed-citation></ref><ref id="DMM022905C45"><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Oksanen</surname><given-names>J.</given-names></name>, <name><surname>Blanchet</surname><given-names>F. G.</given-names></name>, <name><surname>Kindt</surname><given-names>R.</given-names></name>, <name><surname>Legendre</surname><given-names>P.</given-names></name>, <name><surname>Minchin</surname><given-names>P. R.</given-names></name>, <name><surname>O'Hara</surname><given-names>R. B.</given-names></name>, <name><surname>Simpson</surname><given-names>G. L.</given-names></name>, <name><surname>Solymos</surname><given-names>P.</given-names></name>, <name><surname>Stevens</surname><given-names>M. H. H.</given-names></name> and <name><surname>Wagner</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <comment>Vegan: Community Ecology Package; R Package version 2.0-0. University of Oulu: Oulu, Finland, 2011. Available online: <ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org">http://cran.r-project.org</ext-link></comment>.</mixed-citation></ref><ref id="DMM022905C46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.</given-names></name>, <name><surname>Li</surname><given-names>Z.</given-names></name>, <name><surname>Yang</surname><given-names>X. O.</given-names></name>, <name><surname>Chang</surname><given-names>S. H.</given-names></name>, <name><surname>Nurieva</surname><given-names>R.</given-names></name>, <name><surname>Wang</surname><given-names>Y.-H.</given-names></name>, <name><surname>Wang</surname><given-names>Y.</given-names></name>, <name><surname>Hood</surname><given-names>L.</given-names></name>, <name><surname>Zhu</surname><given-names>Z.</given-names></name>, <name><surname>Tian</surname><given-names>Q.</given-names></name><etal>et al.</etal></person-group> (<year>2005</year>). <article-title>A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17</article-title>. <source><italic>Nat. Immunol.</italic></source>
<volume>6</volume>, <fpage>1133</fpage>-<lpage>1141</lpage>. <pub-id pub-id-type="doi">10.1038/ni1261</pub-id><pub-id pub-id-type="pmid">16200068</pub-id></mixed-citation></ref><ref id="DMM022905C47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulson</surname><given-names>J. N.</given-names></name>, <name><surname>Stine</surname><given-names>O. C.</given-names></name>, <name><surname>Bravo</surname><given-names>H. C.</given-names></name> and <name><surname>Pop</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Differential abundance analysis for microbial marker-gene surveys</article-title>. <source><italic>Nat. Methods</italic></source>
<volume>10</volume>, <fpage>1200</fpage>-<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2658</pub-id><pub-id pub-id-type="pmid">24076764</pub-id></mixed-citation></ref><ref id="DMM022905C48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000f6;llinger</surname><given-names>B.</given-names></name>, <name><surname>Junt</surname><given-names>T.</given-names></name>, <name><surname>Metzler</surname><given-names>B.</given-names></name>, <name><surname>Walker</surname><given-names>U. A.</given-names></name>, <name><surname>Tyndall</surname><given-names>A.</given-names></name>, <name><surname>Allard</surname><given-names>C.</given-names></name>, <name><surname>Bay</surname><given-names>S.</given-names></name>, <name><surname>Keller</surname><given-names>R.</given-names></name>, <name><surname>Raulf</surname><given-names>F.</given-names></name>, <name><surname>Di Padova</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Th17 cells, not IL-17<sup>+</sup> &#x003b3;&#x003b4; T cells, drive arthritic bone destruction in mice and humans</article-title>. <source><italic>J. Immunol.</italic></source>
<volume>186</volume>, <fpage>2602</fpage>-<lpage>2612</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1003370</pub-id><pub-id pub-id-type="pmid">21217016</pub-id></mixed-citation></ref><ref id="DMM022905C49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proulx</surname><given-names>S. T.</given-names></name>, <name><surname>Kwok</surname><given-names>E.</given-names></name>, <name><surname>You</surname><given-names>Z.</given-names></name>, <name><surname>Papuga</surname><given-names>M. O.</given-names></name>, <name><surname>Beck</surname><given-names>C. A.</given-names></name>, <name><surname>Shealy</surname><given-names>D. J.</given-names></name>, <name><surname>Ritchlin</surname><given-names>C. T.</given-names></name>, <name><surname>Awad</surname><given-names>H. A.</given-names></name>, <name><surname>Boyce</surname><given-names>B. F.</given-names></name>, <name><surname>Xing</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2007</year>). <article-title>Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography</article-title>. <source><italic>Arthritis Rheum.</italic></source>
<volume>56</volume>, <fpage>4024</fpage>-<lpage>4037</lpage>. <pub-id pub-id-type="doi">10.1002/art.23128</pub-id><pub-id pub-id-type="pmid">18050199</pub-id></mixed-citation></ref><ref id="DMM022905C50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>H.</given-names></name>, <name><surname>Williams</surname><given-names>A.</given-names></name>, <name><surname>Jones</surname><given-names>E.</given-names></name>, <name><surname>Hindley</surname><given-names>J.</given-names></name>, <name><surname>Godkin</surname><given-names>A.</given-names></name>, <name><surname>Simon</surname><given-names>A. K.</given-names></name> and <name><surname>Gallimore</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Novel role of regulatory T cells in limiting early neutrophil responses in skin</article-title>. <source><italic>Immunology</italic></source>
<volume>131</volume>, <fpage>583</fpage>-<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2010.03333.x</pub-id><pub-id pub-id-type="pmid">20722759</pub-id></mixed-citation></ref><ref id="DMM022905C51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scher</surname><given-names>J. U.</given-names></name>, <name><surname>Sczesnak</surname><given-names>A.</given-names></name>, <name><surname>Longman</surname><given-names>R. S.</given-names></name>, <name><surname>Segata</surname><given-names>N.</given-names></name>, <name><surname>Ubeda</surname><given-names>C.</given-names></name>, <name><surname>Bielski</surname><given-names>C.</given-names></name>, <name><surname>Rostron</surname><given-names>T.</given-names></name>, <name><surname>Cerundolo</surname><given-names>V.</given-names></name>, <name><surname>Pamer</surname><given-names>E. G.</given-names></name>, <name><surname>Abramson</surname><given-names>S. B.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis</article-title>. <source><italic>Elife</italic></source>
<volume>2</volume>, <fpage>e01202</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.01202</pub-id><pub-id pub-id-type="pmid">24192039</pub-id></mixed-citation></ref><ref id="DMM022905C52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schett</surname><given-names>G.</given-names></name>, <name><surname>Stolina</surname><given-names>M.</given-names></name>, <name><surname>Dwyer</surname><given-names>D.</given-names></name>, <name><surname>Zack</surname><given-names>D.</given-names></name>, <name><surname>Uderhardt</surname><given-names>S.</given-names></name>, <name><surname>Kr&#x000f6;nke</surname><given-names>G.</given-names></name>, <name><surname>Kostenuik</surname><given-names>P.</given-names></name> and <name><surname>Feige</surname><given-names>U.</given-names></name></person-group> (<year>2009</year>). <article-title>Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis</article-title>. <source><italic>Arthritis Rheum.</italic></source>
<volume>60</volume>, <fpage>2644</fpage>-<lpage>2654</lpage>. <pub-id pub-id-type="doi">10.1002/art.24767</pub-id><pub-id pub-id-type="pmid">19714640</pub-id></mixed-citation></ref><ref id="DMM022905C53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarzenberger</surname><given-names>P.</given-names></name>, <name><surname>Huang</surname><given-names>W.</given-names></name>, <name><surname>Ye</surname><given-names>P.</given-names></name>, <name><surname>Oliver</surname><given-names>P.</given-names></name>, <name><surname>Manuel</surname><given-names>M.</given-names></name>, <name><surname>Zhang</surname><given-names>Z.</given-names></name>, <name><surname>Bagby</surname><given-names>G.</given-names></name>, <name><surname>Nelson</surname><given-names>S.</given-names></name> and <name><surname>Kolls</surname><given-names>J. K.</given-names></name></person-group> (<year>2000</year>). <article-title>Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis</article-title>. <source><italic>J. Immunol.</italic></source>
<volume>164</volume>, <fpage>4783</fpage>-<lpage>4789</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.164.9.4783</pub-id><pub-id pub-id-type="pmid">10779785</pub-id></mixed-citation></ref><ref id="DMM022905C54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonderegger</surname><given-names>I.</given-names></name>, <name><surname>Iezzi</surname><given-names>G.</given-names></name>, <name><surname>Maier</surname><given-names>R.</given-names></name>, <name><surname>Schmitz</surname><given-names>N.</given-names></name>, <name><surname>Kurrer</surname><given-names>M.</given-names></name> and <name><surname>Kopf</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival</article-title>. <source><italic>J. Exp. Med.</italic></source>
<volume>205</volume>, <fpage>2281</fpage>-<lpage>2294</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20071119</pub-id><pub-id pub-id-type="pmid">18779348</pub-id></mixed-citation></ref><ref id="DMM022905C55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>C.</given-names></name>, <name><surname>Brereton</surname><given-names>C.</given-names></name>, <name><surname>Keogh</surname><given-names>B.</given-names></name>, <name><surname>Mills</surname><given-names>K. H. G.</given-names></name> and <name><surname>Lavelle</surname><given-names>E. C.</given-names></name></person-group> (<year>2006</year>). <article-title>A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis</article-title>. <source><italic>J. Exp. Med.</italic></source>
<volume>203</volume>, <fpage>1685</fpage>-<lpage>1691</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20060285</pub-id><pub-id pub-id-type="pmid">16818675</pub-id></mixed-citation></ref><ref id="DMM022905C56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>D.</given-names></name>, <name><surname>Kagari</surname><given-names>T.</given-names></name>, <name><surname>Doi</surname><given-names>H.</given-names></name> and <name><surname>Shimozato</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Administration of anti-type II collagen antibody sustains footpad swelling of mice caused by a delayed-type hypersensitivity reaction and induces severe arthritis</article-title>. <source><italic>Clin. Exp. Immunol.</italic></source>
<volume>148</volume>, <fpage>360</fpage>-<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2007.03354.x</pub-id><pub-id pub-id-type="pmid">17335554</pub-id></mixed-citation></ref><ref id="DMM022905C57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>W. B.</given-names></name> and <name><surname>McInnes</surname><given-names>I. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Th17 cells and IL-17 A - focus on immunopathogenesis and immunotherapeutics</article-title>. <source><italic>Semin. Arthritis Rheum.</italic></source>
<volume>43</volume>, <fpage>158</fpage>-<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/j.semarthrit.2013.04.006</pub-id><pub-id pub-id-type="pmid">24157091</pub-id></mixed-citation></ref><ref id="DMM022905C58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>N. C.</given-names></name>, <name><surname>Crotti</surname><given-names>T. N.</given-names></name>, <name><surname>Goldring</surname><given-names>S. R.</given-names></name> and <name><surname>Gravallese</surname><given-names>E. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Rheumatic diseases: the effects of inflammation on bone</article-title>. <source><italic>Immunol. Rev.</italic></source>
<volume>208</volume>, <fpage>228</fpage>-<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1111/j.0105-2896.2005.00338.x</pub-id><pub-id pub-id-type="pmid">16313352</pub-id></mixed-citation></ref><ref id="DMM022905C59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanders</surname><given-names>A.</given-names></name>, <name><surname>Heijde</surname><given-names>D. v. d.</given-names></name>, <name><surname>Landew&#x000e9;</surname><given-names>R.</given-names></name>, <name><surname>B&#x000e9;hier</surname><given-names>J.-M.</given-names></name>, <name><surname>Calin</surname><given-names>A.</given-names></name>, <name><surname>Olivieri</surname><given-names>I.</given-names></name>, <name><surname>Zeidler</surname><given-names>H.</given-names></name> and <name><surname>Dougados</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial</article-title>. <source><italic>Arthritis Rheum.</italic></source>
<volume>52</volume>, <fpage>1756</fpage>-<lpage>1765</lpage>. <pub-id pub-id-type="doi">10.1002/art.21054</pub-id><pub-id pub-id-type="pmid">15934081</pub-id></mixed-citation></ref><ref id="DMM022905C60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name>, <name><surname>Garrity</surname><given-names>G. M.</given-names></name>, <name><surname>Tiedje</surname><given-names>J. M.</given-names></name> and <name><surname>Cole</surname><given-names>J. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Na&#x000ef;ve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy</article-title>. <source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>73</volume>, <fpage>5261</fpage>-<lpage>5267</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00062-07</pub-id><pub-id pub-id-type="pmid">17586664</pub-id></mixed-citation></ref><ref id="DMM022905C61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.-J.</given-names></name>, <name><surname>Ivanov</surname><given-names>I. I.</given-names></name>, <name><surname>Darce</surname><given-names>J.</given-names></name>, <name><surname>Hattori</surname><given-names>K.</given-names></name>, <name><surname>Shima</surname><given-names>T.</given-names></name>, <name><surname>Umesaki</surname><given-names>Y.</given-names></name>, <name><surname>Littman</surname><given-names>D. R.</given-names></name>, <name><surname>Benoist</surname><given-names>C.</given-names></name> and <name><surname>Mathis</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells</article-title>. <source><italic>Immunity</italic></source>
<volume>32</volume>, <fpage>815</fpage>-<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2010.06.001</pub-id><pub-id pub-id-type="pmid">20620945</pub-id></mixed-citation></ref><ref id="DMM022905C62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yago</surname><given-names>T.</given-names></name>, <name><surname>Nanke</surname><given-names>Y.</given-names></name>, <name><surname>Ichikawa</surname><given-names>N.</given-names></name>, <name><surname>Kobashigawa</surname><given-names>T.</given-names></name>, <name><surname>Mogi</surname><given-names>M.</given-names></name>, <name><surname>Kamatani</surname><given-names>N.</given-names></name> and <name><surname>Kotake</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-&#x003b1; antibody: a novel mechanism of osteoclastogenesis by IL-17</article-title>. <source><italic>J. Cell. Biochem.</italic></source>
<volume>108</volume>, <fpage>947</fpage>-<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.22326</pub-id><pub-id pub-id-type="pmid">19728295</pub-id></mixed-citation></ref><ref id="DMM022905C63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaiss</surname><given-names>M. M.</given-names></name>, <name><surname>Frey</surname><given-names>B.</given-names></name>, <name><surname>Hess</surname><given-names>A.</given-names></name>, <name><surname>Zwerina</surname><given-names>J.</given-names></name>, <name><surname>Luther</surname><given-names>J.</given-names></name>, <name><surname>Nimmerjahn</surname><given-names>F.</given-names></name>, <name><surname>Engelke</surname><given-names>K.</given-names></name>, <name><surname>Kollias</surname><given-names>G.</given-names></name>, <name><surname>Hunig</surname><given-names>T.</given-names></name>, <name><surname>Schett</surname><given-names>G.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Regulatory T cells protect from local and systemic bone destruction in arthritis</article-title>. <source><italic>J. Immunol.</italic></source>
<volume>184</volume>, <fpage>7238</fpage>-<lpage>7246</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0903841</pub-id><pub-id pub-id-type="pmid">20483756</pub-id></mixed-citation></ref><ref id="DMM022905C64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name>, <name><surname>Zhang</surname><given-names>D.</given-names></name>, <name><surname>Jia</surname><given-names>H.</given-names></name>, <name><surname>Feng</surname><given-names>Q.</given-names></name>, <name><surname>Wang</surname><given-names>D.</given-names></name>, <name><surname>Liang</surname><given-names>D.</given-names></name>, <name><surname>Wu</surname><given-names>X.</given-names></name>, <name><surname>Li</surname><given-names>J.</given-names></name>, <name><surname>Tang</surname><given-names>L.</given-names></name>, <name><surname>Li</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment</article-title>. <source><italic>Nat. Med.</italic></source>
<volume>21</volume>, <fpage>895</fpage>-<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3914</pub-id><pub-id pub-id-type="pmid">26214836</pub-id></mixed-citation></ref></ref-list></back></article>